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ABSTRACT 
 
 
BACKGROUND AND AIM: Diet, in particular dietary fats, and cardiovascular disease (CVD) are 
closely related. Dietary fats might be captured by measuring blood fatty acid profiles. The role of diet as 
well as the role of blood fatty acid (FA) levels, in CVD aetiology is still uncertain. Aims of this thesis 
were to investigate in a large cohort of 60-year-old Swedish men and women: 1) The association between 
self-reported dietary intake, with a specific focus on foods rich in fat, and selected serum cholesterol ester 
FAs (Project I); 2) The relation between self-reported intake of specific types of dietary fats (primary 
aim) and fruit and vegetables (secondary aim) and incident of CVD and all-cause mortality (Project II); 3) 
The relation between serum cholesterol FAs, with a specific focus on polyunsaturated FAs 
(PUFA)eicosapentaenoic acid (EPA), docosaesaenoic acid (DHA), linoleic (LA) and linolenic (ALA) 
acid and incident CVD and all-cause mortality (Project III). 
 
METHODS: Data collected between 1997 and 1998 from 4,232 individuals (2,039 men and 2,139 
women) aged 60, randomly selected from Stockholm County were used. The participants were followed 
regarding incident CVD up to 31
st 
December 2012 using national registers yielding 359 incident CVD 
cases and 595 deaths. From nutritional data, collected by questionnaires, we created: 1) five diet scores 
reflecting intake of saturated fats in general, and fats from dairy, fish, processed meat and vegetable oils 
and margarines (Project I, II) 2) binary variables classifying study participants into exposed and 
unexposed and evaluating 16 specific dietary factors (Project II). Gas chromatography was used to assess 
13 FAs in serum cholesterol esters (Project I, III). Association between each diet score and specific FAs 
was assessed by percentile differences (PD) with 95% confidence intervals (CI) at the 10
th
, 25
th
, 50
th
, 75
th
, 
and 90
th
 percentile of each FA across levels of diet scores using quantile regression (Project I). Crude and 
adjusted Cox proportional hazards models were used to estimate hazard ratios (HR) with 95% CI in the 
association between specific self-reported dietary fats (diet scores and single dietary items), fruit and 
vegetables intake (Project II) and serum PUFA (Project III) and incidence of CVD and all-causes 
mortality.  
  
RESULTS: In men and women combined, fish intake was associated with high serum proportions of 
EPA (50
th
PD=31.41, 95% CI= 27.77; 35.05) and DHA (50
th
PD=10∙51, 95% CI= 9.40; 11.62). Vegetable 
fat intake was associated with high serum proportion of total PUFA (50
th
PD 36.34, 95% CI= 22.77;49.92) 
and low proportion of total SFA (50
th
PD=11.33,  95%CI= 14.92;7.73). (Project I) In women, an 
increased risk of CVD  was related to high consumption of spread butter or margarine (≥10g/day vs 
<10g/day), HR=1.49, CI=1.02 ; 2.20, and oily potatoes (≥2 times/week vs <2time/week), HR=2.00, 
CI=1.11;3.60. In men, an increased risk of early death was related to the consumption of butter (vs 
margarine), HR=1.28, CI=1.01; 1.62, high consumption of spread butter or margarine, HR=1.57, 
CI=1.23; 2.02 and egg consumption ≥4 times/week (vs <4times/week), HR=1.53, CI=1.15;2.02. In men, 
daily intake of fruits (vs <1time/day) was inversely related to early death, HR=0.75, CI=0.60; 0.94. 
(Project II) High serum EPA and DHA proportions were inversely associated with CVD in women (for 
EPA HR= 0.79, 95% CI 0.64; 0.97; for DHA HR= 0.74 0.61; 0.89) but not in men. Inverse associations 
with early death were also noted in men for  high serum EPA proportion, HR=0.82, 95% CI 0.71;0.95; 
and  DHA proportion, HR= 0.82, 95%CI= 0.71;0.94, and in women for high serum EPA proportion, 
HR=0.79, 95%CI= 0.65;0.96, and  DHA proportion, HR= 0.78, 95% CI= 0.66;0.93.  High serum ALA 
proprotion was associated with moderately increased of CVD incidence, HR= 1.16, 95% CI=1.02;1.32 in 
women whereas high serum LA proportion was associated with reduced all-cause mortality in men, HR= 
0.73 95% CI=0.64;0.83. (Project III). 
 
CONCLUSION: Based on our results, self-reported intake of fish and vegetable fats was clearly 
associated with serum PUFA. High intake of specific foods and not fats in general may have negative 
effects on CVD for women and all-causes mortality for men, whereas fruit may reduce mortality only in 
men. Similarly serum EPA, DHA and LA were protective for CVD and all-causes mortality with gender 
difference whereas serum ALA might be associated with increased of CVD in only women. 
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INTRODUCTION 
 
Cardiovascular disease  
Epidemiology  
Cardiovascular disease (CVD) is the leading cause of death worldwide
1
. (Fig.1) Among them, coronary 
heart disease (CHD) - including stable and unstable angina pectoris, myocardial infarction (MI), heart 
failure and sudden death - and ischemic stroke are the most common manifestation of CVD
2
.  
 
 
Fig 1: Age-standardized deaths due to cardiovascular disease (rate per 100,000), 2004 
According to World Health Organization (WHO) data, 17.5 millions of death each year are for CVD. Of 
these, 7.6 million are attributed to CHD and 5.7 million to stroke
1
. In Europe nearly half of all death is for 
CVD (47% - 52% in women and 42% in men): CHD is the main cause of CVD death- 1.8 million of 
death whereas stroke is the second cause accounting for 1.1 million deaths. Death rate from CHD and 
stroke is generally higher in Central Europe than in Northern, Southern and Western countries
3
.  In 
Sweden, since 1980s overall mortality rates from CVD have been declining by 53.4 in men and 52% in 
women in all age group
4
. Specific Swedish data of mortality of CHD and stroke are reported in Appendix, 
Table 1-2. 
Aetiology  
Although the aetiology is multifactorial, atherosclerosis is the main cause of CHD and ischemic stroke.  
Atherosclerosis is an inflammatory disease in which immune mechanism interact with metabolic risk 
factors to initiate, propagate and activate lesions in the arterial tree
5,6
. Several hypotheses have been 
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proposed to explain the initiation event in atherogenesis, e.g. the response to injury, response to retention, 
and oxidation process. These hypothesis are not mutually exclusive and may even be compatible with 
each other
7
. The oxidation hypothesis empathize the importance of oxidative modification in the 
atherosclerotic process, because compared to native LDL, oxidized LDL is preferentially taken up in the 
arterial wall. This hypothesis makes a role of diet and, in general lifestyle in atherogenesis.  
Atherosclerotic lesions (atheromata) are asymmetrical focal thickenings of the innermost layer of the 
arteria, the intima. They consist of cells, connective tissue elements, lipids and debris. Blood-borne 
inflammatory and immune cells constitute an important part of an atheroma, the remainder being vascular 
endothelial and smooth-muscle cells
6
. The atheroma is preceded by fatty streak, an accumulation of lipid 
laden cell beneath the endothelium. Most of the cells in the fatty streak are macrophages, together with 
some T cells. Fatty streak are prevalent in young people and may progress to atheromata or eventually 
disappear. In the centre of the atheroma, foam cells and extracellular lipid droplets form a core region, 
which is surrounded by a cap of smooth-muscle cells and a collagen-rich matrix
6
. T cells, macrophages 
and mast cells infiltrate the lesions and are particularly abundant in the shoulder region where the 
atheroma grows. Many of the immune cells exhibit signs of activation and produce inflammatory 
cytokines
6
. 
Coronary and cerebrovascular ischemia is for the most cases due to the formation of an occluding 
thrombus on the surface of the plaque. Plaque rupture and endothelial erosion are the main causes of 
thrombosis
8,9
.  
Plaque rupture (60-70% of the case) exposes pro-thrombotic material from the core of the plaque 
(phospholipids, tissue factors and platelet-adhesive matrix molecular) to the blood. Rupture occurs where 
the fibrous cap is thin and partly destroyed. In these sites activated immune cells are abundant. They 
produce several inflammatory molecules and proteolytic enzymes that can weaken the cap and activate 
cells in the core, transforming the stable plaque into a vulnerable unstable structure that can rupture and 
induce thrombosis
6
. (Fig 2) 
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Fig 2:Atherosclerosis Lesion in a Human Artery (source Ross et al.) 
Endothelial erosion of the plaque (20-25% of cases) has received less attention than the plaque rupture. 
The apoptosis of endothelial cells could contribute to their desquamations. Oxidative stress can promote 
endothelial apoptosis- generally hypochlorous acid. The product of myeloperoxidase, an enzyme released 
by activated leucocyte associated with atheromata- can initiate the apoptosis and consequently production 
of pro-coagulant tissue factors. Endothelial cells can also express proteinases that may sever their tethers 
to the underlying basement membrane-activation of matrix metalloproteinase that can catalyse the initial 
attack on fibrillar collagen
10
. 
Risk Factors 
The risk factors for CVD, including CHD and stroke are well known. Traditionally these potential risk are 
divided in non-modifiable - sex, age, family history, genetics- and modifiable - diabetes, dyslipidaemia, 
hypertension, obesity, diet, smoking, physical activity, psychological factors. 
Non-modifiable risk factors 
 
Age is linear related with CHD and stroke. Ethnic origin plays a role: African or Asian are at higher risks 
of developing cardiovascular disease than other racial groups
11
. 
Men are at greater risk of coronary heart disease than a pre-menopausal woman.  But once past the 
menopause, a woman’s risk is similar to a man’s. Risk of stroke is similar for men and women2. 
However, CVD prevalence tends to be higher for men than for women. Yet, women experience their first 
cardiovascular events later in life, approximately 9 years later than men
12
. Similarly, a recent review of 
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stroke found that men have their first stroke an average 4.3 earlier than women
13
 . The reason most often 
cited for these gender differences is the protective role of oestrogen on the development of CVD risk 
factors- blood lipids, blood pressure
14
. Other factors that could contribute to decreased CVD incidence 
and mortality rate in women than in men could be related to the lower prevalence of smoking in women. 
However, women are more likely to be sedentary than men and increased prevalence in obesity has been 
noted among women compare to men. Unique in women is the pregnancy and postpartum period in which 
women are at increased risk of stroke
14
. 
Strong predictor of CHD is premature family history of cardiac events, since it has long been observed 
that coronary atherosclerosis tend to aggregate in families
15
. The National Cholesterol Education Program 
Third Adult Treatment Panel (NCEP ATP III) recommended that age of onset should be before age 65 in 
the father and 55 in the mother
16
. In the Cardio200 study, it was observed that family history of CHD was 
associated with about 4 fold time increased of non-fatal acute coronary event in male and 3 fold increased 
in female. No gender differences were observed regarding the effect of family history on coronary heart 
disease. The risk for non-fatal acute coronary event was multiplicative increased when family history of 
hypertension, diabetes and hypercholesterolemia were also accounted for in the risk models. Moreover, a 
sibling history has been more strongly associated than parental history with subclinical atherosclerosis
17
.  
Such predictive power of a positive family history is the hallmark of genetic component in the aetiology 
of CVD. There are several well characterized single and gene disorder that might be contribute to CVD 
such as certain forms of familiar hypercholesterolemia linked to mutation of the apolipoprotein B gene 
and during the past few years, there have been major advance in the identification of genetic risk factors 
for CHD, stroke risk factors thank to the advent of genome-wide association study (GWAS). GWAS 
identified multiple genetic variants that increased susceptibility to atherosclerosis and its risk factors 
(blood lipid and blood pressure in specific). The identification of the genetic loci 9p21.3 associated 
strongly with CHD and myocardial infarction has led to identified 47 chromosomal loci all of which 
increase the susceptibility to coronary heart disease. However, variant at these loci explain less than 10% 
of the heritability of CHD and a common scientific view suggested that genetic of CVD involved a 
complex interplay of many different genes and much work remains to develop thorough understanding of 
the complex gene-gene and gene-environmental interaction involved in the developed of CVD
18
. 
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Modifiable risk factor 
 
Smoking  
 
In the Global burden of Disease study, Lopez et al. have estimated that 880,00 death from CHD and 
412,00 deaths from stroke were attributable to tobacco - based on the estimates of the relative risk of 
death among smokers for CHD, stroke and hypertensive heart disease
19
. Smoking cessation has been 
shown to have significant impacts on reducing CHD as reported in a major review of the evidence where 
the authors determined that successful smoking cessation reduce CHD mortality risk by up to 36%. 
Although the specific timeline of reduction depend on the number of years and cigarettes smoked daily, it 
is conceivable that, over time, former smokers CVD risk can drop to levels similar to that of someone 
who has never smoked
20
 . Consensus in the literature is that CVD risk drops precipitously within the first 
2 to 3 years of smoking cessation. WHO 2008 data source has shown that smoking rates are higher among 
poorest populations and women
21
. 
 
Physical activity 
 
Physical activity has been showed to be associated with CVD independently by the effects on weight and 
obesity. Increasing of physical activity has been shown to decrease the risk of CHD and stroke, the risk of 
some risk factors related to CVD including diabetes, obesity, hypercholesterolemia and hypertension.  As 
previous published, the general trend of physical activity is decreasing in developing countries. Globally, 
with the exception of several European Eastern countries women are more likely to be physically inactive 
than men, adults over 50 years of age were more likely to be inactive then younger adults and city dweller 
more than the country inhabitants
22
. 
 
Obesity/Overweight 
A review on the evidence of the relation between obesity and risk of CVD concluded that obesity and 
overweight confer a significantly elevated risk of CHD and stroke
23
 . The association is partly but not 
completely mediated through hypertension, hypercholesterolemia and diabetes. Abdominal obesity in 
particular is associated with both CHD and stroke independently of BMI. One of the key contributors to 
obesity is excess in energy intake for a higher consumption of foods that that can vary across countries. 
However, in general worldwide trend showed rapid increases in oil use and slow decline in the 
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consumption of cereal as contributors to calories. Increasing in sugar consumption food and in particular 
in sugar sweeteners beverage (including soft drinks, juice drink and energy and vitamin water drink)
24
. 
 
Hypertension 
A review of the global burden of hypertension shows that 54% of stroke and 47% of coronary heart 
disease are attributable to hypertension. Among the major underlying risk factors for hypertension are 
daily salt intake, body weight and access to treatment
25
.  
 
Dislipidemia 
High blood concentrations of low density lipoprotein (LDL), triglycerides and lower of high-density 
particle (HDL) are associated with increased risk of CVD. The INTERHEARTH study has showed that 
abnormal lipids were the most important risk factors for myocardial infarction by odd ratio in all global 
regions
26
. Successful intervention program in a number of countries has further supported the causal link 
between dyslipidaemia and CVD by demonstrating that reductions in cholesterol lead to decrease CVD 
morbidity and mortality e.g. Finland.  
Modification of LDL to form oxidized LDL has been showed to be important in both initiation and 
progression of atherosclerosis. Lipoprotein (a) - an LDL like particle- has been independently associated 
with higher risk of CHD and stroke in a recent meta-analysis
27
.  Lipoprotein-associated Phospholipase A2 
(Lp-PLA2) - an enzyme bound to LDL that hydrolyses oxidized phospholipids on oxidized LDL with the 
generation of pro inflammatory markers as lysophosphatidylcholine and oxidized LDL- has been shown 
to be associated with primary event and recurrences of MI and stroke. Moreover, a recent publication 
showed an independent association between the functional property of HDL, cholesterol efflux capacity, 
and atherosclerotic cardiovascular disease in a large population based cohort, free from cardiovascular 
disease
28
.  
 
Diabetes 
CVD risk is linearly associated with blood glucose. Thus individual without a diagnosis of diabetes but 
who are at increased risk of developing diabetes in future, have a higher risk of CVD. People with 
diabetes have a more than 2 fold greater risk of fatal and non-fatal CVD compared to non-diabetics. In 
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2001, 1.49 million of death from CHD and 709,000 from stroke were attributable to high blood glucose
29
. 
The most single risk factors for diabetes 2 is obesity but unhealthy diet, physical inactivity independently 
raise the population risk for diabetes. The prevalence of diabetes is worldwide growing; according to 
WHO source around 347 million of people have diabetes. 
 
Psychosocial factors 
Psychosocial factors have been consistently associated with both the onset and the progression of CVD in 
large epidemiological prospective studies in several populations. These factors include depression, 
anxiety, anger, hostility acute and chronic stress and lack of social support.  Depression and personality so 
called type A are the most recognized factors associated with an increased risk of CVD
30
.  
 
Air pollution 
Over the past 20 years, there has been an increasing body of evidence linking air pollution to higher risk 
of CVD. Several epidemiological studies showed that both short and long term exposure to particulate 
matter air pollution significantly increases cardiovascular events and CVD death.
11
 In these studies, the 
relative risk of CVD mortality increased by approximately 1% for every 10 microgram/m
3 
increase in 
daily concentration of fine particle pollution. Despite the robust epidemiological evidence of air 
pollution´s negative effect on CVD incidence and mortality, the specific mechanism by which particulate 
matter increase CVD risk are still unclear. Different mechanism have been proposed, specifically thought 
the activation sympathetic nervous system, release of pro inflammatory or oxidative stress inducing 
compounds from the lung and soluble particulate matter entering in the blood stream after inhalation that 
directly act on the cardiovascular system. 
 
Fatty acids  
 
Fatty acids are the basic structural components of triglycerides (TGs) and are also found in phospholipids 
and cholesterol esters. Fats provide functions as storage units for energy (9Kcal for each 1g of fat), 
structural units in membranes and precursors to eicosanoids
31
. 
Chemically, fatty acids are characterized by methylene group on one side that impart hydrophobic 
characteristics and carboxyl group on the other side of a carbon backbone. Their nomenclature vary for 
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the length of the chain, number of double bonds (called unsaturation) and the position of the first double 
bond on the carbon chain opposite the carboxyl group. The characteristics of the fatty acids are important 
because may affect the chemical and physical properties of the fatty acids (e. double bond confer liquidity 
to the fatty acids). 
The most known categorization of the fatty acids is based on the double bonds: saturated fatty acids 
(SFA) -no double bonds-, monounsaturated (MUFA) - one double bond- polyunsaturated fatty acids - 
more than one double bond-. Moreover, the double bond may be in cis- or trans- configuration when the 
hydrogen atoms attached to the double bonds are on the same or opposite side respectively. The most 
common shorthand notation is the following: C:D n- (or omega/ω) where C is the number of carbons 
atoms, D the number of unsaturation and n- refers to the positions of the first double bound closest to the 
methyl end of the fatty acid.  
Fat digestions, metabolism and physiology 
Fatty acids in human body are derived by the dietary fats and in part they are produced endogenously 
through synthesis, elongation and desaturation process. Fats in food are mainly contained in triglycerides. 
Since the fatty acids are water insoluble compounds, they can not be transferred to the enterocytes in their 
intact form. Therefore, the ingested TGs are emulsified and hydrolysed to monoacylglycerols and free 
fatty acids prior the absorption. The digestive process requires different enzymes secreted in the digestive 
system. Usually, the entire fat digestive and absorption process lasts for 16-24h. Briefly, the dietary fat is 
masticated and mixed with lingual lipase, followed by hydrolysis by gastric lipase in the stomach and 
then by pancreatic lipase in the small intestine
32
. The TGs are first hydrolysed by a gastric acid lipase 
which predominantly attacks the short-and medium chain fatty acids in the position 3 of the TGs 
molecule. The gastric lipase is responsible for up to 20% of total TG hydrolysis. The short and medium 
fatty acids released in this step are absorbed directly into the bloodstream from the stomach. Further, the 
further triglycerides (around 80%) and the remainder of the partially digestive hydrolysis products formed 
primarily by gastric lipase are hydrolysed in the upper part of the duodenum to form monoglycerides 
(generally with PUFA in position 2) where the action of pancreatic lipases together with bile salts, 
lysophospholipids and unesterified cholesterol form mixed micelles from which the digest lipids are 
absorbed in the small intestine. These micelles are aggregate in a way that polar (hydrophilic) ends of the 
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molecules face the water and the non-polar portion (hydrophobic) form the core and are very small 
particles and easily diffuse the microvilli of the enterocyte of the intestinal wall
32
. In humans, the 
absorption of most commons dietary fatty acids and fats in general is>95%. However, according some 
studies some fatty acids e.g. stearic acid might be low
33
. 
Fatty acids of chain length shorter than C12 which are directly absorbed across the gut wall as individual 
fatty acids and bounded to albumin and are transported to the liver where they are rapidly oxidized. The 
other absorbed lipids are esterified to newly TGs and phospholipids in the smooth endoplasmatic 
reticulum and are used to synthetize chylomicrons, together with apoproteins, which are secreted to the 
lymph and then to the general blood stream
32
. In the peripheral tissue they are cleaved by lipoprotein 
lipase –loosing TG and chylomicrons remnants, interchanging components with other lipoproteins - and 
are taken up by the liver. The other lipoproteins differ in lipids and protein composition and size and are 
classified according to the density. Briefly, the larger triacylglycerol-rich chylomicrons and the very low 
density lipoproteins (VLDL) are mainly involved in delivery of triacylglycerols to tissue. The smaller low 
density lipoproteins (LDL) and the high density lipoproteins (HDL) are more involved in the regulation of 
the cellular cholesterol content. LDL particles deliver cholesterol to the cells whereas HDL particles 
remove cholesterol and transport it to the liver for excretion
34
. 
Saturated fatty acids 
Saturated fatty acids are classified according to the chain length in short (2-7 carbons atoms), medium (8-
13 carbons) and long (14-20 carbons) and very long (>20 carbons). The most common saturated fatty 
acids in the diet are in Fig 3. 
 
 
Fig. 3: Main common SFA in foods 
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The majority of saturated fatty acids are transformed through elongation and desaturation in new fatty 
acids with longer length and in monounsaturated fatty acids. Exception is for the acid pentadecanoic 
(15:00) and 17:00 heptadecanoic fatty acids. These two fatty acids have an uneven carbossilic chain can 
not be metabolized and transformed by human enzymes and are only synthetized by bacterial flora in the 
rumen
35
.  
 
Monounsaturated fatty acids 
The common MUFA in the diet are described in Fig 4.  In general, they have an even number of carbon 
atoms, between C14-C24 and the double bond is mostly located in position n-9. Oleic acid, palmitoleic 
acid are the most common MUFA. The oleic acid is the most widely distributed of all the natural fatty 
acids. As the saturated fatty acids, MUFA might be synthetized endogenously by saturated fatty acids 
thought specific elongases and desaturases. Moreover, erucic acid is also important in human diet 
occurring in seed oils of plants in the family of Brassicaceaae, particularly in mustard oil and high erucic 
rapeseed oil (40-60%). Since in animal model -but not in human- acid erucic has been shown to promote 
myocardial lesion, it has been removed from rapeseed plants in the most part of the world.  
 
 
Fig 4: Main common MUFA in food 
Polyunsaturated fatty acids 
PUFA are divided in n6 and n3 families. Linoleic (LA) and alfa-linolenic acid (ALA) are the main fatty 
acids and are the precursors. LA and ALA are also essential fatty acids that must be provided by the diet 
because the human body lack the enzymes delta 12 and delta 15 desaturases that capable of introducing 
double-bonds at the n6 and n3 positions. They are synthetized only in plant sources
36
. (Fig.5)  
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Fig 5: Pathway of n-6 and n-3 fatty acids metabolism 
n-6 PUFA 
As introduced earlier, the main n-6 PUFA is the linoleic acid. It occurs often in the diet and in particular 
in some vegetables oils as sunflower, safflower, corn and soybean oils. (Fig.6) Because it is widely 
distributed in main common dietary fats, many population overconsumed LA and the intake of n3 fatty 
acids is very often lower than ideal. The metabolism of LA is presented in Fig.5. Physiologically, AA and 
DGLA are the most important conversion products of LA. Both are substrates for eicosanoids, involved in 
a variety of physiological actions including modulating inflammation, platelet aggregation, immune 
response, cell growth and proliferation, contraction and dilatation of smooth muscle cells
33
. 
 
 
Fig 6: Main common n-6 in food 
n-3 PUFA 
ALA is the main n3. It occurs in very high concentrations in flaxseed oil (55%) and perilla oil. Among the 
common vegetable oils is present in the canola (6-10%)and soybean oils(5-8%). The other important n3 
PUFAs are acid eicosapentaenoic (EPA) and docosapentaenoic acid (DHA) which are major components 
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of marine lipids. Fish as mackerel, salmon, sardine herrings, are excellent source. (Fig.7) EPA and DHA 
are also precursors of eicosanoids.  
 
 
Fig 7: Main common n-3 PUFA in food. 
Trans fatty acids 
Trans fatty acids do not occur in nature excepting for small amounts (2-6%) in ruminants -particularly 
dairy products. The majority of fatty acids come from technological treatment - as partial hydrogenations 
of oils - to produce fat blends for margarine, shortening and deep fat frying
33
.  
 
Diet 
Dietary fats in Sweden  
In Sweden, the most important source of dietary fat are 1) spread, butter and oils 2) milk and dairy 
products 3) meat products 4) fish 5) nuts. 
Generally, fat containing dairy product, butter, butter based spread, meat product, sweet, bakery product 
and confectionary are the main source of SFA, represented by palmitic acid, following by stearic and 
myristic. Dairy product and meat product are also the main food containing pentadecanoic acid and 
heptadecanoic acids.  
MUFA are derived from several group of food. However, rapeseed oils and liquid margarines are the 
main source of MUFA and in specific 18:1n9. Soft margarines, vegetables oils, nut and fish are the main 
source of PUFA. In specific, the n6 linoleic acid is the main PUFA in the diet and it is present mainly in 
vegetables oils (90%) as sunflower and soybeans oils. The n-3 alfa-linoleic acid is encompassed in high 
concentration in linseed oil (55%). Fish in particular fatty fish (mackerel, salmons, herrings) are the main 
source of EPA and DHA
37,38
. 
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Fig 8: Percentage contribution of SFA, MUFA and PUFA from group foods in Sweden 
 
Fig 9: Percentage contribution of n-6 and n-3 PUFA from group foods in Sweden 
 
Trends in diet 
In Europe, the amount of fats present in the food supply has remained relatively stable overall since 1990 
after a great decline from 1970 when nutritional campaign were adopted to reduce dietary content of 
saturated fat and cholesterol.  Moreover, recent FAO data have shown an increase of fruit and vegetables 
much of Europe. In the Nordic countries vegetables intake has been shown to increase gradually in recent 
decade where the consumption of fruit has increased dramatically, now equally the high consumption 
levels in the Southern Europe
3
.  
These global results are confirmed in Swedish national data. A Swedish nutritional survey was conducted 
1997-98 (Riksmaten) aiming to carry out differences in nutritional habits in the Swedish population in last 
decades (survey so called Hulk, 1989)
39
. The results indicate that certain changes in dietary habits have 
occurred since the first survey carried out in 1989. In Riksmaten a more frequent consumption of juice 
and nectar, pizza, rice, pasta, nuts and snacks and sweets were seen for both men and women. Women 
also more often consumed vegetables, milk, meat and poultry and alcoholic beverages, and men more 
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often consumed jam and marmalade, ice cream, and soft drinks. A less frequent consumption was seen for 
cheese, offal, bread, sweet bakery products, spreads, cream and sugar (as additional foods), and desserts. 
Men also less frequently consumed eggs, fish, pulses, and porridge. The observed differences in 
consumption frequency were mostly reflected in consumed amounts. Exceptions were bread and sweet 
bakery products. A higher consumption was also seen for vegetables (men), sausages (men and women), 
meat and poultry (men). Part of these differences could be explained by changes in the standard portion 
sizes used in the record book. 
Moreover, results from the market basket study 2010- a Swedish survey performed by the National Food 
agency with the purpose of obtaining information on level of nutrients in foods- have showed that the 
proportion of SFA, MUFA, PUFA in the current market basket was similar to that in previously market 
basket 2005 and 2002. However, the supply of total fat is higher, mainly due to larger contribution from 
sugar and sweet in which chocolate and cream are high in fat
38
. 
 
Swedish recommendations for dietary fats and group of food in general 
According to Swedish National Recommendations (SNR 2012), total fat content of the diet should not 
provide more than around 30% of energy: saturated fat should be restricted to at most 10% energy and the 
content of PUFA should lie between 5-10% (1% from n3 fatty acids).The mean of total fat intake have 
remained stable from 1997 to 2011 (34%) and the intake of SFA has slightly decreased from around 
14%E to 13%E where the intake of PUFA has increased from a mean of 4.7%E to 5.6%.  Although, from 
1960 to 1990 the dietary content of trans fatty acids has decreased in all the Nordic countries (primarily 
through reduced use of partially hydrogenated fats in food production) and the dietary content of PUFA 
have increased, the proportion of SFA is still above the recommendations and the ratio of unsaturated to 
saturated fatty acids is below the recommendation in the Nordic countries
40,41
.  
 
Meat products 
Six to seven portion of meat per week, including sandwiches meat and lean (average of 5%) and fatty 
meat(15% of fats). Sausage is included once per week. Reindeer and other game are included once a 
month where three eggs per week are recommended
41
.  
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Fish 
Lean and fatty fish and seafood are included twice to three times per week including in the sandwiches
41
. 
  
Milk, cheese and other dairy product 
The recommendation is that 500 ml of milk per day is sufficient still holds true. Assuming that 10-15 g of 
cheese are equivalent to 100 ml of milk, low fat milk and cheese (<=17% of fats) are the choices on most 
occasions. The amount of cheese is the maximum possible and it is equivalent of a cheese sandwich every 
day. The current consumption of cheese is slightly above the recommendations (28g/day for women and 
31g/d for men) and is for cheese with high fat content. The cream included in the food list is cooking 
cream (15% fat) and equivalent products with a low fat content
41
. 
 
Margarine and oil for spreading 
Margarine and oil for spreading, cooking and salad dressing contribute around 38% of fat. Around 40% 
of margarine and oil is intended for spreading and the rest for cooking and salad dressing. One slice of 
bread is assumed to use 5g if a spread with 60% fat is chosen, it mean that for women is allowed 3-4 
slides with spread per day and for men five. Sandwiches with spreadable filling such as liver pate or whey 
cheese are assumed to not include margarine. Spread fat can be varied regards to the type and quantity of 
fats that are in the different products. Important factor is to keep the total amount of fat originating from 
spread constant and to choose a margarine that includes a high content of unsaturated fatty acids. There is 
no place for butter on bread. Fat for cooking is mainly liquid margarine or oil. Solid margarine is only 
used for baking; butter can in that case replace solid cooking margarine
41
. However, the consumption of 
butter results to be doubled from 1998 to 2012
42
.  
 
Leeway 
Leeway defined as savoury snacks, pastries, cakes, ice cream, jam, sweet and alcoholic drinks should be 
restricted as most as possible
41
.  
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Bread 
From 6 to 8 slices (assuming that one slice of breads is 25g) depending on sex. Two kind of bread are 
used: fibre rich group consist of bread with a 6g/100 and above e.g. crispy bread and wholemeal rye bread 
whereas the group with lower fibre content (<6g/100g) include e.g. white bread and refined rye bread. 
Potatoes, rice and pasta are recommended for every meal. More frequency in the use of potato is 
recommended than rice and pasta because potatoes are still the most common staple food
41
.  
 
Fruit and vegetables 
The recommendations for fruit and vegetables intake are 500g per day. Fruits is calculated on 12 type of 
common fruit and berries. Juice is also included at most 100g per day. Vegetables are divided in 200 
groups:1) group with more fibre (>2g/100g) and include e.g. broccoli, white cabbage, beans, peas 
spinach, carrots and other root vegetables 2) group with less fibre (<2g/100g) e.g. lettuce, tomatoes, 
cucumber, pepper, onion and mushroom. Concerning pulses (peas and beans) the recommended amount 
is about 28g and 31g/d for women and men respectively where the real amount consumed is three times 
smaller
41
.  
Dietary assessment methodology 
In nutritional epidemiology, there are different method to asses self-reported dietary intake:1) dietary 
record 2) 24-hour dietary recall 3) Food frequency and Brief dietary Assessment Instruments 4) Diet 
history. 
 
Dietary record 
The respondent records the foods and beverages and the amount of each consumed over one or more 
days. Ideally, the recordings are done at the time of the eating occasion in order to avoid reliance on 
memory. The amounts consumed may be measured, using a scale or house-hold measures (cup or 
tablespoon) or estimated, using models, pictures or no aid. If multiple days are recorded, they are usually 
consecutive and no more than 7 days are included. The dietary record method has the potential for 
providing quantitatively accurate information on food consumed during the recording period. By 
recording foods as they are consumed, the problem of omission may be lessened and the foods more fully 
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described. Measurement of amounts of foods consumed at each occasion should provide more accurate 
portion size than if the respondents were recalling sizes of foods previously eaten. A potential 
disadvantage is that is subject to bias both in the selection of the sample and the sample´s compilation of 
the number of days recorded. Moreover, recording foods as they are being eaten can affect both the type 
of food chosen and the quantities consumed. Unless dietary records are collected electronically, the data 
can be burden-some to code and can lead to high personal cost
43
. 
 
24-hour dietary 
In the 24 hour dietary recall, the respondent is asked to remember and report all the food and beverages 
consumed in the preceding 24 hours or in the precedent day. The recall is typically conducted by 
interview- in person or by telephone, although self-electronic administration has recently become 
available. Ideally, interview would be dieticians with education in foods and nutrition. A quality control 
system to minimize error and increase reliability of interviewing and coding 24 hours recalls is essential. 
There are many advantages. When an interviewer administers the tools and records the responses, literacy 
of the respondent is not requested. For self-administered versions, literacy can be a constraint. Because of 
the immediacy of the recall period, respondents are generally able to recall most of their dietary intake. 
There is relatively little burden on the respondents, those who agree to give 24 hours dietary recall are 
more likely to be representative of the population than are those who agree to keep food records. Thus it 
can be useful across a wide range of populations. In addition, dietary recall occurs after the food has been 
consumed, so there is less potential for the assessment method to interfere with dietary behaviour. Main 
weakness of the 24 hours recall approach is that individuals may not report their food consumption 
accurately for various reasons (knowledge, memory and interview situation)
43
. 
 
Food frequency approach 
The food frequency approach asks respondents to report their usual frequency of consumption of each 
food from a list of food for a specific period. Information is collected on frequency, but little detail is 
collected on the other characteristics of the foods as eaten, such as the method of cooking, or the 
combination of foods in meals. Overall nutrient intake estimates are derived by summing, over all foods, 
the products of the reported frequency of each food by the amount of nutrient in a specified (or assumed) 
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serving of that food to produce an estimated daily intake of nutrients, dietary constituents and food 
groups. FFQ approach is inexpensive and the required time to complete it is usually short. The major 
limitation is that it contains a substantial amount of measurement error. Many detail of dietary intake are 
not measured and the quantification of intake is not as accurate as with recall or records
43
.  
A short version of the food frequency is the Brief Dietary Assessment Instruments. It is also called 
screeners. These instruments might be useful in situations that do not require either assessment of the total 
diet or quantitative accuracy in dietary estimates. Several limitations: they do not capture information 
about the entire diet. Most measures are not quantitatively meaningful and the estimate of dietary intake 
for the population usually may not be made. Even when measures aim to provide estimate of the total 
intake, the estimate are not precise and have a large measurement error
43
. 
 
Diet history 
A dietary history is any dietary assessment that asks the respondent to report about past diet. The major 
strength is its assessment of meal patters and details of food intake rather than intakes for a short period of 
time or only frequency of food consumption. A weakness of the approach is that respondents are asked to 
make many judgements about both the usual foods consumed and the amounts of those foods eaten
43
. 
Measurement of fatty acids in serum  
Measurement of fatty acids in blood and or adipose tissue is generally used to capture the dietary intake in 
particular the fat intake. Fatty acids composition of a wide variety of biological sample has previously 
measured. However, the lipid pools most often reported in literature are subcutaneous adipose tissue, 
plasma total phospholipids, cholesterol ester, triacylglycerol (TAG), total plasma lipids, platelet and 
erythrocytes
44
.  
Fatty acid composition of serum cholesterol ester (CEs) has been assessed in association dietary intake in 
several epidemiological studies. Cholesterol can exit free or esterified to a single fatty acid as CE. In 
blood, approximately two thirds of cholesterol is in the esterified form
45
. The intracellular enzyme 
responsible for the synthesis of CE from cholesterol and acyl-CoA is acyl-CoA-choelsterol acyl 
transferase (ACAT), which has specificity for 18:1 n9
46
. So the majority of absorbed cholesterol is 
esterified in the enterocyte either by reverse of cholesteryl esterase or via CAT. These enzymes are also 
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responsible for the formation of CE for storage within other cells and for providing CEs for VLDL 
secretion liver. CEs may also be formed in the blood and in humans the esterification largely takes place 
in plasma by the transfer of fatty acids from sn-2 position of PC in particles containing apoA1 (such as 
HDL) under the influence of lecithin-cholesterol acyl transferase (LCAT). The specificity for human 
LCAT is reported to be in the order 18:2 n-6>18:1 n-9<20:4 n-6>SFA which accounts for the high 
proportion of 18:2n6 in CEs. Moreover, selectivity for 20:5n-3 over 22:6 n-3 have been shown for LCAT. 
Since in the serum there are higher proportion of 18:2 n-6 than 18:1 n-9 in CE, that means that the 
majority of plasma CE must derive from LCAT, rather than ACAT
47
. Over half of CE fatty acids are 18:2 
n-6 (52(47.1-54.6) %), 16:0 (13.6(10.9-18.3) %), 18:1 n-9 (19.3 (15-23) %). The abundance of 16:1 n-
7(4(2.8-6.8) %) and 20:4 n-6 (5.1(2.5-7.7) %) are similar. Serum fatty acids reflects intake of the last few 
days or hours.  
 
Diet and blood fatty acids 
 
Several studies have investigated the relation between diet and blood fatty acid profiles. The most 
consistent findings are for fish intake. In these studies, fish intake was associated with blood 20:5n-3 
(eicosapentaenoic acid, EPA) and 22:6n-3 (docosaesaenoic acid, DHA) 
48-56
. Studies that investigated 
whether fats from intake of dairy products associate with blood fatty acid composition have identified a 
relation between fats from dairy products and blood levels of odd-chained saturated 15:0 (pentadecanoic 
acid) and 17:0 (heptadecanoic acid), particularly in Swedish populations
57-60
. Few studies have 
investigated how blood or tissue fatty acid profile relates to intake of fats from processed meat and 
eggs
56,61,62
. Studies that investigate foods containing a high polyunsaturated/saturated fat ratio report 
varying results, depending on population characteristics such as ethnicity
56,62,63
.  Studies that examine 
how foods rich in saturated fats relate to blood levels of saturated fatty acids (SFA) and/or 
monounsaturated fatty acids (MUFA) have shown discrepant results: some investigations report clear 
relations, others do not
51,54,56,63-72
.  
 
Diet in relation to CVD  
 
Diet might play a prominent role in the onset of CVD. The relation between diet and CVD has been 
studied extensively. The prominent role of diet on CVD is related to the atherosclerosis process. In the 
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1950, controlled feeding studies have showed an increase of serum cholesterol ester in relation to 
saturated fatty acid intake
73
. Meanwhile, epidemiological studies found that increased serum cholesterol 
predicted risk of CVD in human population. These discoveries set the base for the diet-heart hypothesis, 
which postulated a primary role of dietary saturated fat and cholesterol in the cause of atherosclerosis and 
CHD in human
74
. This hypothesis gained further support from ecological associations relating saturated 
fats and cholesterol to rates of CHD in cohort from different countries and from studies of migrants from 
low to high risk countries.  However, the original hypothesis was overly simplistic (correlation does not 
imply causation) because the effect of diet on CHD can be mediated through multiple biological pathway 
other than serum cholesterol and LDL cholesterol 
75
.  In these past two decades, understanding of food 
and nutrients likely to promote the effect on CVD has grown substantially owing to studies of mechanism 
of atherosclerosis and the metabolic effect of foods.  Although several epidemiological and dietary 
interventional studies have been performed, evidence of the association of dietary foods and in particular 
dietary fats intake on CVD is still controversial
76,77
.   Research in this complex field is still necessary in 
order to improve the understanding of this relationship and to prevent CVD. 
 
Results from a recent meta-analysis of prospective cohort studies showed that saturated fats consumption 
was not associated with risk of CVD including as endpoint CHD and stroke
78
.  However earlier single 
prospective and interventional studies have showed a positive and or inverse association between 
saturated fats intake and CVD
78-80
. However, diet source of saturated fatty acids might be important. Yet, 
different prediction in relation to CVD depend on the complex of food matrix and not only from the 
single fatty saturated fatty acids that encompassed in the foods
81,82
. 
Studies that examined the association between dairy consumption (milk, cheese, butter, cream, yogurt, ice 
cream) and risk for CVD including CHD and stroke, as well all causes or CVD death showed 
controversial results
83
. Recent meta-analyses and prospective cohort studies showed a decrease, increase 
and no risk of CVD (and all cause of mortality) and intake of dairy product (See Rice review). In general, 
cheese intake is associated with reduced risk where a positive or no association has been showed for milk 
and butter. (Ref) Still some association between dairy intake and risk of CVD and total mortality have 
been observed only in women and not for men or vice versa. Same contrast results come from studies that 
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evaluating whether low dairy products were associated to reduction on the risk of CVD (or total 
mortality) compared to high fats dairy intake
83
.  
Studies that have investigated whether meat consumption was related to CVD (and total mortality) have 
showed no protective or harmful association between red meat intake and different chronic disease 
whereas processed meat intake has been noted to increase the risk of CVD and all-causes mortality in 
several study
84,85
.  Regarding egg consumption and risk of cardiovascular disease, the results remains 
controversial. A recent meta-analysis have noted that a consumption of eggs up to one per day was not 
associated with increased risk of CHD or stroke whereas other studies have found a reduced risk in CHD 
and stroke in relation a low consumption of eggs (less than 2 time per week)
86
.  Few studies have 
investigated the role of eggs on total mortality and the most have been performed in men
87-89
. 
Few epidemiological studies have been investigated the relation between vegetables oils and risk of CVD 
and total mortality
90
. Evidence from interventional studies have shown a reduced CHD risk (and total 
mortality) when fats from animal original riched in saturated fatty acids were replace for vegetables 
oils
77,91
. 
On the other hand, fat intake from fish, mainly EPA and DHA, have been shown to be protective on CVD 
through anti-inflammatory, anti-thrombotic, anti-arrhythmic hypotrygliceridemic effect and involved in 
mechanism of vascular relaxation and plaque stability
92
. However, a recent meta-analysis noted an 
inverse association between fish consumption and the risk of CHD and stroke, single prospective studies 
are inconsistent showing a positive association or no association
93
. Moreover, few studies have evaluated 
association between fat fish intake and CVD in men and women separately
93
. 
Beside fats, other specific foods have been found associated with CVD. Generally, fruit and vegetables 
have been shown to reduce the risk of CVD and the evidence is stronger for vegetables than for fruits
80
.  
However, the effect of fruit and vegetable on total mortality is still uncertain
94
. 
Few studies have focused whether other specific food as French fried, pastry, chocolate, are associated to 
the risk of CVD. Yet the results are still poor of evidence. 
 
Blood fatty acids in relation to CVD  
 
Blood and tissue fatty acids might capture self-reported dietary intake and in particular fats intake
44
. 
Previous studies have investigated the association between fatty acids and CVD using blood fatty acids 
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instead of the dietary fats intake to predict the risk of CVD
95
. Fatty acids might be involved in the onset of 
CVD, and in specific atherosclerosis, thought different mechanisms (e.g. pro-atherogenic, pro-
inflammatory, anti-inflammatory)
91,96
. It has been shown that the different effects of fatty acids on the 
metabolism depend on type of fatty acids
34,97
.  Moreover, discrepant evidence came from studies relating 
dietary fats and CVD and blood fatty acids and CVD
95
. In general, prospective studies showed no clear 
association between dietary intake of saturated, MUFA, PUFA, n6 and n3, and CVD whereas intake of 
alfa-linolenic acid have been shown to be protective for CVD
95
. A recent meta-analysis investigating the 
association between circulating fatty acid and risk of CVD has showed no clear association between 
blood total saturated, total monounsaturated, total n-3 and n-6 fatty acids and the risk of CVD
95
. 
However, considering individual fatty acids, 17:00, EPA and DHA, and arachidonic acid have been 
showed to be associated with a reduce risk of CVD
95
. Yet, few studies have considered sex-specific 
association between fatty acids and risk of CVD
90
. 
 
Rational for this thesis 
 
Diet, in particular dietary fats and CVD are closely related. Dietary fats might be captured in blood fatty 
acids profile
44
. Investigations in this field are still useful to understand possible underlying biological 
mechanism involved in CVD. Furthermore, several previous studies have shown as both dietary and 
blood fats might affect a variety of metabolic factors -inflammatory, lipids, glucose- involved in the 
atherosclerotic process and generally in the onset of CVD
97
. However, the role of dietary fatty acids and 
blood fatty acids, in specific saturated fatty acids and polyunsaturated fatty acids, in the association with 
incidence of CVD is still uncertain
95
. Thus, clearly further investigations are needed. The rational of this 
thesis was to improve knowledge how specific self-reported dietary habits and fats relate to blood or 
adipose tissue composition of fatty acids and clarify the role of dietary self- reported habits and blood 
fatty acids in relation to CVD. 
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AIMS 
 
The overall aim of this project thesis was to study the association between dietary fats with specific focus 
on food rich in fats and risk of cardiovascular disease (CVD) in a large cohort of 60-year-old Swedish 
men and women living in Stockholm County, Sweden. 
 
The specific aims of this thesis were to investigate in a large cohort of 60-year-old Swedish men and 
women: 
 
1) The association between self-reported dietary intake with a specific focus on foods rich in fat 
and selected fatty acid cholesterol esters measured in serum (Project I).  
 
2)  The relation between specific kind of fats intake and incident of CVD -including angina, 
myocardial infarction and stroke, and all-cause mortality in men and in women separately. A 
secondary aim was then to investigate the association between fruit and vegetables intake and 
incidence of CVD and all-causes of mortality. (Project II). 
 
3) The relation between serum cholesterol fatty acids with a specific focus on serum 
polyunsaturated fatty acids (PUFA) including acid linoleic, alfa-linolenic, eicosapentaenoic and 
docosaesaenoic and incident of CVD and all-causes mortality in men and women separately. 
(Project III)  
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SUBJECTS AND METHODS (Project I, II,III) 
The projects of this thesis are based on the data from the population-based cohort of 60 years old men and 
women residing in Stockholm County, Sweden. The design of the projects is described in the table below. 
 
 
 
Fig.10: Study design of Project I-III 
 
Study population 
 
Project I, II, III are based on data collected from men and women who participated in a screening of 
cardiovascular disease risk factors between August 1997 and March 1999. Every third man and woman 
living in Stockholm County who was born between 1 July 1937 and 31 June 1938 (60 years old) was 
invited to participate. Of these (5,460), 4,232 (78% response rate), 2,039 men and 2,193 women, agreed 
to participate. The participants underwent a physical examination that included anthropometric 
measurements (height, weight, waist, hip, and sagittal abdominal diameter). Blood pressure was also 
measured and blood samples were drawn after overnight fasting. The participants completed an extensive 
questionnaire that included providing information about their disease history, health status, medication 
therapy, lifestyle, and nutritional habits. 
The study was conducted according to the guidelines laid down in the Declaration of Helsinki and all 
procedures involving human subjects were approved by the Ethical Committee at Karolinska Institutet 
(Institutional review board), registration number 96-398. Verbal informed consent was obtained from all 
participants.  
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Dietary assessment  
 
Dietary assessment was considered as exposure in Project I and Project II. The questionnaire included 16 
questions on current habits regarding the consumption of 16 specific food items: 1) sandwiches, 2) type of 
spread butter or margarines, 3) quantity of butter and margarine, 4) cheese, 5) milk or yoghurt, 6) fruits, 
7) vegetables, 8) lean fish, 9) fatty fish, 10) sausages or bacon, 11) visible fat of meat, 12) potato dishes, 
13) eggs, 14) type of oil or spread butter or margarine used to panfry, 15) cream or sour cream (“crème 
fraiche”), and 16) desserts or snacks. Each question had either three or four possible answers. (Appendix, 
Table 3) By the three or four alternative answers binary variables were created classifying study 
participants into exposed and unexposed to 16 specific dietary factors for Project II. 
In addition, we created five diet scores: dairy score (Dairyscore); meat score (Meatscore); saturated fat 
score (Satscore); vegetable oil score (Vegoilscore); and fish score (Fishscore). As the names suggest, the 
five diet scores represented the intake of specific foods: Dairyscore reflects intake of dairy products 
(butter, cheese, milk, yoghurt, and cream); Meatscore reflects intake of sausages, bacon, visible meat fats, 
and eggs; Satscore reflects intake of dairy products, sausages, bacon, and eggs; Vegoilscore reflects 
intake of margarines and vegetable oils; and Fishscore reflects intake of fatty and lean fish. Because 
questions about intake of sandwiches, fruits, vegetables, potatoes dishes, and pastries/desserts were not 
clearly associated with specific fatty acids, they were not included in any scores. For each question, we 
gave score points based on three categories previous created –low, intermediate, high intake–. (data not 
shown) The alternative answer “zero”, reflecting a zero quantity of fats, generated 0 points, the 
intermediate level of fats generated 1 point, and high intake generated 2 points. (Appendix, Table 4) Each 
diet score was based on the individual sum of points generated by the question(s).  
We used diet scores (continuous) for Project I and both diet scores and the single dietary questions 
(binary) for Project II. 
 
Measurement of serum cholesterol fatty acids  
 
Serum cholesterol ester fatty acids were used for Project I as outcome and for Paper III as exposure. Fatty 
acids in serum cholesterol were analysed as described in detail by Boberg et al.
98 
Briefly, serum samples 
were stored at -80°C until the analyses were performed in 2012. The percentage composition of 
methylated fatty acids was determined by gas chromatography (GC) with a flame ionization detector 
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(FIO) and helium as the carrier gas.  The GC system used for the analysis consisted of 30-m glass 
capillary column coated with Thermo TR-FAME (Thermo Electron Corporation, USA), an Agilent 
Technologies system consisting of model GLC 6890N, an autosampler 7683, and Agilent ChemStation. 
The temperature was programmed to 150°C - 260°C.  
Thirteen fatty acids were identified using standards from Nu Check Prep (Elysian, MN, USA). Total SFA 
were calculated as sum of all measured SFA, and total MUFA and total PUFA were calculated as the sum 
of all measured MUFA and all measured PUFA, respectively. The ratio 16 : 1n-7/16 : 0 (SCD16) was 
calculated as ratio of 16 : 0 to 16 : 1n-7. The SCD16 reflects the activity of the rate-limiting enzyme 
stearoyl-COA desaturases, which transforms saturated fatty acids 16 : 0 into the MUFA 16 : 1n-7. SCD16 
is often used to estimate the proportion of conversion from SFA to MUFA.  
Measured fatty acids were expressed as the percentage of the sum of the total fatty acids (%) that were 
analysed. In our population, the assessments of fatty acid profile failed in 15 samples. In 67 subjects, the 
fatty acid profile is missing because the available amount of the serum was too small. Overall, 4,150 
samples were available for further analysis.  
Percentile of serum fatty acids at 10
th
, 25
th
, 50
th
, 75
th
, and 90
th
 were used as outcome in Project I where 
continuous values and quartile of serum fatty acids were used as exposure in Project III. 
 
Endpoint definition 
 
The endpoint was incidence of CVD and all-causes mortality in Project II-III. CVD and all-causes 
mortality were defined using the Hospital Care Register and the Cause of death register in Sweden
99,100
. 
Total CVD incidence was first time ischemic CVD event including fatal and non-fatal myocardial 
infarction, fatal and non-fatal ischemic stroke and hospitalization due to angina pectoris - International 
classification of Disease 10
th
 revision (ICD-10) codes: I20, I21, I25, I46, and I63-I66-. All-cause 
mortality included all causes of deaths -ICD-10, codes I1-I99-. All participants were followed regarding 
incident of CVD and death up to 31
st
 December 2012. During the follow-up (median 14.5 y), 306 men 
and 185 women suffered from their first CVD event. By then end of the follow-up time, 359 men and 236 
women had died. Participants that had a prior event of CVD at the baseline were excluded by analysis in 
Project II-III. 
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Confounding factors 
 
To be a confounder, a variable must be related to the exposure and independently associated with the 
outcome (Fig.11) 
 
Fig 11: Directed Acyclic Graph (DAG) of the concept of confounder 
 
In the analysis, possible confounding factors were taken in consideration and adjusted for. In Project I we 
adjusted for sex, smoking status and physical activity, in Project II smoking status, physical activity and 
education, in Paper III smoking status, physical activity, education, alcohol intake diabetes, 
hypercholesterolemia, hypertension, BMI, alcohol intake.  
Smoking status was categorized as never smokers and ever smokers (current smokers plus former 
smokers). Physical activity during leisure time in the past year was categorized as either inactive (inactive 
and light activity at least two hours/week) or active (moderate activity 1-2 times/week or intensive 
activity ≥3 times/week). Three categories of education level were formed: 1) <9 years of school 
(compulsory school); 2) 9-12 years of school (secondary); and 3) >12 years of school (university or 
college). Pre-diabetes was defined as fasting glucose levels between ≥6.1 mmol/l and ≤6.9 mmol/l, a 
range found in fasting glucose (FG) diagnostic criteria. Diabetes was defined as fasting serum glucose 
level ≥7.0 mmol/l (WHO cut-off) or self-reported diagnosis of diabetes or use of anti-diabetics 
medication. Hypertension was determined as systolic blood pressure ≥140 mmHg or diastolic blood 
pressure ≥90 mmHg or self-reported diagnosis of hypertension or use of anti-hypertensive medication. 
Hypercholesterolemia was defined as
 total cholesterol ≥6.45 mmol/l or self-reported ypercholesterolemia 
or use of lipid-lowering drugs. Hypertriglyceridemia was defined as triglycerides >2.3 mmol/l. Alcohol 
intake was classified as <1 drink (=14 g ethanol) per wk, <1 drink/d, <2 drink/d, and ≥2 drink/d (Project 
III) 
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Statistical methods 
 
Baseline demographic characteristics were summarized by their median values and interquartile range 
(IQR) for continuous variables and proportions for categorical variables. (Project I, II, III) The 10
th
, 25
th
, 
50
th
, 75
th
, and 90
th 
percentile values were used to describe the distributions of serum cholesterol fatty 
acids (Project I-III). Analyses were performed in the entire sample and then in men and women 
separately. Sex differences in the distribution of serum fatty acids were tested using the Wilcoxon’s rank 
sum test (Mann-Whitney’s test) for continuous variables. Differences across sex were considered 
significant at 0.05. All statistical analyses were performed using STATA version 12.1 (Stata Corp, 
College Station, TX, USA). 
Project I 
Diet score were the exposure of interest and they were treated as continuous variable. The outcome was 
percentile of serum cholesterol fatty acids at 10
th
, 25
th
, 50
th
, 75
th
, and 90
th
. 
Each diet score was associated to specific serum cholesterol fatty acids selected according to current 
knowledge about what fatty acids are encompassed in different dietary items, and based on the current 
literature. Dairyscore – 14 : 0, 15 : 0, 16 : 0, 18 : 0, 16 : 1n-7, 18 : 1n-9, SCD16, Total SFA and Total 
MUFA; Meatscore – 14 : 0, 15 : 0, 16 : 0, 18 : 0, 16 : 1n-7, 18 : 1n-9, and SCD16; Satscore – 14 : 0, 15 : 
0, 16 : 0, 18 : 0, 18 : 1n-9, SCD16, Total SFA, and Total MUFA; Vegoilscore – 18 : 2n-6, 18 : 3n-3, Total 
PUFA, Total SFA; and Fishscore – 20 : 5n-3, and 22 : 6n-3. 
Quantile regression was used to estimate the association between diet score and fatty acids. Percentile 
differences (PD) at the 10
th
, 25
th
, 50
th
, 75
th
, and 90
th 
percentile of each fatty acid were calculated. The 
PD’s were estimated with 95% confidence intervals and were interpreted as increase (positive regression 
coefficient) or decrease (negative regression coefficient) at the specified percentile of the proportion of 
serum fatty acids for each point’s increase of the specific diet scores. Quantile regression is a regression 
method in which instead of modelling the mean, we model the percentiles of the distribution.  
Interpretation of the results is the same of the linear regression but applied to the percentiles of the 
distribution and not only mean. Quantile regression is useful in particular for those variables (as diet or 
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serum fatty acids) that might have a different distribution at different percentiles of the population 
distribution and can be skewed.  Thus, quantile regression gives a more detailed description of the 
considered association and allows analysis to the entire distribution (where the linear regression estimates 
only the mean of the distribution)
101
. Subanalysis were performed using diet score as categorical variable. 
Sex specific stratified analyses were performed to investigate possible differences in the relation dietary 
score and fatty acids.  
 
Project II 
The exposure of interest were diet score treated as continuous variable and single questions treated as 
binary (0=risky factor,1=protective) where the outcome was binary (yes/no) either for incidence case of 
CVD and all-causes mortality. Cox proportional hazard model (HR) and 95% of confidence interval (CI) 
were used to estimate the relation between self-reported dietary intake- scores and single questions - and 
incidence of CVD and all-causes mortality in men and women separately. In addition to crude model 
adjustment for possible confounder smoke, physical activity and education were run.  
Subanalysis was also performed to investigate specific relation between exposure and MI and stroke.  
In sensitive analysis, to exclude possible effect of other confounders and/or intermediate factors that 
could explain the results of the estimate, we also adjust for country of birth, hypercholesterolemia, 
hypertriglyceridemia, hypertension, obesity (BMI>30), diabetes, family history- binary variables (yes/no) 
- duration of menstruation and total SFA, MUFA, PUFA, n-3 and n-6 serum cholesterol fatty acids - 
continuous variables. 
 
Project III 
The exposure of interest was serum cholesterol fatty acids (continuous and quartile) and the outcome was 
categorized as binary of incidence case of CVD and all-causes mortality. To estimate the relation between 
serum specific PUFA fatty acids- acid linoleic, alfa-linolenic, eicosapentaenoic and docosaeaenoic -and 
CVD and all-causes mortality we used Cox proportional Hazard model with 95% of confidence interval. 
Analyses were run separately in men and women. To avoid possible effect of potential confounders we 
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adjust for potential confounders including smoke, physical activity, education, obesity, alcohol intake, 
diabetes, hypertension and hypercholesterolemia. 
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RESULTS 
 
Baseline characteristics of all participants, in men and women separately, are shown in Table 1 where 
Table 2 shows demographic, anthropometric, risk and metabolic factors between CVD and not CVD 
individuals.  
The percentile values (at 10
th
, 25
th
, 50
th
, 75
th
, and 90
th
) of serum cholesterol fatty acids proportion (%) are 
shown in Table 3. As expected, linoleic acid (18:2 n6;  n-6 PUFA) was the major fatty acids in serum 
cholesterol followed by 18:1 (oleic acid, MUFA) and 16:00 (palmitic acid, SFA) fatty acids whereas the 
least common fatty acid was pentadecanoic acid (15:0, SFA). Sex-specific differences in fatty acids 
distribution were found in: all specific SFA, in total MUFA including palmitoleic acid (16:1), total n6 
with gamma linoleic acid (18:3n6) and total n3 including alfalinolenic acid (18:3 n-3) and DHA. No 
sex differences were observed for oleic acid, linoleic acid, diomogamma linolenic (20:3 n-6) and total 
PUFA. (Appendix, Table 6) 
The distributions of the diet score points were as follow (median, IQR; range): Dairyscore 5, (4−7; 112) 
(n=4107); Meatscore 1, (02; 06) (n=4105); Satscore 7, (5−9;117) (n=4105); Vegoilscore 2, (1−2; 
04) (n=4105); Fishscore 2, (1−2; 04) (n=4105). Lower points of Satscore, Dairyscore and Meatscore 
were noted in women than men whereas no differences for Fishscore and Vegoilscore. (Appendix, Table 
5)  
 
Project I 
Dietary fats and serum cholesterol fatty acids relation  
Estimates from quantile regression modelling of each diet score, in relation to the percentiles (10
th
, 25
th
, 
50
th
, 75
th
, 90
th
) of serum cholesterol of fatty acids are shown in Table 4. Each point of increase of 
Fishscore associate with an increase of serum proportion of 20:5n3 (EPA) and 22:6n3 (DHA) in crude 
models and models adjusted for sex, smoke and physical activity (model 1) (Table 4, a). The increases of 
these fatty acids for each unit´s increase of the Fishscore were greater in the upper part (90
th 
percentile) 
than in the lower part (10
th 
percentile) of the distribution (Fig 9a9b). EPA showed greater percentiles 
differences than DHA. Moreover, in sex stratified analysis a clearer increase of EPA, DHA in relation to 
each unit´s increase of Fishscore was noted in men compared to women.  
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A high Vegoilscore was associated to increase of serum proportion of total polyunsaturated fatty acid and 
decrease of total proportion of saturated Table 4, b. The change of PUFA in relation to each unit´s 
increase of the Vegoilscore was higher in the lower side of the PUFA distribution (10
th 
percentile) than in 
the upper (90
th 
percentile) (Fig 1c). The absolute coefficient of total SFA increased with the order of 
quantile (from 10
th
 to 90
th
 percentiles) whereas the decrease of the total SFA was observed to be similar 
across percentile (Fig 1d). Moreover, a higher intake of vegetable oil associated with an increase of 
linoleic acid serum proportion (18:2n6) in the crude model but not in the upper part of the distribution 
(90
th
) after adjustment.  The coefficient of linoleic acid decreased, with the order of the quantile (from 
10
th
 to 90
th
 percentiles). In sex stratified analysis, a similar pattern of association between Vegoilscore 
and specific fatty acids was showed.  
A slight increase of 14:00, 15:00 and 18:00 serum cholesterol fatty acids was associated with Dairyscore, 
Satscore whereas Meatscore was not clearly associated with any specific fatty acid. (Table 4ce). The 
estimated coefficients of these diet scores were not generally monotone functions of the order of the 
quantile (from 10
th
 to 90
th
 percentiles). In sex stratified analysis (Appendix, Table 7) we observed no clear 
different association between Dairyscore, Meatscore, Satscore and the selected fatty acids. 
A clear association has been found between the five single questions and serum cholesterol fatty acids. In 
particular, we noted: 1) a decrease of 20:4n6 (arachidonic acid) and increase of serum 18:3n3 (linoleic 
acid) for each unit increase of intake of sandwiches; 2) a decrease of serum proportion of EPA and DHA 
for each unit increase of intake of potatoes dishes; 3) increase of EPA and DHA for each unit increase of 
fruits, 4) decrease of MUFA mainly oleic acid, increase of serum PUFA, in particular EPA and DHA  
with each unit increase in the intake of vegetables; 5) decrease of serum  16:00 and 16:1n7 and increase 
of  linoleic acid, PUFA and n6 for each unit increase of intake of dessert or snacks. (Appendix, Table 8a-
e) 
 
Project II 
Dietary fats intake in relation to incidence of CVD  
We found no association between general fat intake consumption (diet scores) and incidence of CVD in 
both men and women (Table 5). However, single specific dietary fatty foods were associated to incidence 
of CVD in women but not in men. Consumption of more than 10g/day of butter and margarine (vs<than 
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10g/day) and more than 2 times per week of “oily” potato -pan-fried potatoes, French fries or potato au 
gratin- (vs <than 2 times per week) increased the risk of CVD in women. (Table 6) These results have no 
explanation in lifestyle factors (smoking and physical activity) and education. No potential intermediate 
factors  country of birth, hypercholesterolemia, hypertrygliceridemia, hypertension, obesity, diabetes 
and total SFA, MUFA, PUFA, n-3 and n-6 serum cholesterol fatty acids  showed to affect the estimates 
described above  (data not shown).  
We also looked at the specific associations with CVD, MI and stroke. We noted the following adjusted 
associations in women when studying MI as an outcome: Dairyscore (HR 1.24, CI 1.06-1.44), Satscore 
(HR 1.15, CI 1.03-1.30), intake of potato (HR 3.12, CI 1.11-8.84) and >10g/d butter or margarine (vs 
<10g) (HR 2.30, CI 1.12-4.71). In men, in adjusted model, Fishscore was associated with MI (HR 0.73, 
CI 0.55-0.98) whereas the single question about visible fat in meat was related to stroke (HR 1.85, CI 
1.15-2.97). (Data not shown) 
Dietary fat intake in relation to all-causes mortality 
Specific groups of fats intake (Dairyscore, Satscore, Vegoilscore, Meatscore) were associated with overall 
mortality risk in crude model but these results were explained by lifestyle and education factors. (Table 
5). For each point´s increase of Dairyscore and Satscore we observed an increased risk of overall 
mortality in both men and women (Table 2). Yet, in men the risk of early death decreased for each point´s 
increase of Vegoilscore whereas increased for each point´s increase of Meatscore.  
Consumption of spread butter instead of margarines, intake of margarine or butter more than 10g/day and 
eggs more than 4 times per week increased total mortality in men. (Table 6) Adjustment for smoking, 
physical activity and levels of education attenuated the estimates, in particular for consumption of spread 
butter  where lower confidence interval bound was near to 1.00. But still these factors not explained 
these findings (Table 2). We noted no evidence that country of birth and metabolic factors 
(hypercholesterolemia, hypertrygliceridemia, hypertension, obesity, diabetes) could explain these 
associations in men. However, increased mortality risk associated with intake of butter was no longer 
significant after adjustment for total MUFA (HR 1.22, CI 0.96-1.54), PUFA (HR 1.21, CI 0.96-1.53)  and 
n6 (HR 1.23, CI 0.97-1.55) serum fatty acids (data not shown).  
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We found other sex-specific associations between specific intake of single foods and all-causes mortality 
that were not anymore longer after adjustment. (Table 6) 
Fruit and vegetables consumption in relation to incidence of CVD and all-causes mortality 
Independently by smoking, physical activity and education, intake of fruits more than 1 time per day was 
protective for all-causes mortality in men (Table 7). In crude models, we found that consumption of fruit 
more or equal to 1 times/day was protective for CVD in both men and women and for all-causes mortality 
in women(Table 2) where intake of vegetables, roots, tubers more than 1 time per day decreased mortality 
in both men and women. However, these results were partly explained by smoking, physical activity and 
education since the upper confidence interval bound exceeds 1.00. (Table 7) 
  
Paper III  
Serum cholesterol PUFA in relation to incidence of CVD  
High serum EPA and DHA proportion were associated with CVD incidence in women. After adjustments 
for potential confounders, a 1-SD increase in EPA and DHA among women resulted in 21% and 26% 
reduced risks CVD, respectively. (Table 8)  Women in the highest quartile of EPA and DHA had 40 % 
lower risk of CVD, respectively. (Appendix, Table 9a) However, after adjustment for serum DHA, EPA 
was not associated with CVD: HRs 0.97 (95% CI 0.74-1.28) per 1-SD increment (data not shown). ALA 
was associated with increased CVD incidence among women (Table 8) and women in the highest ALA 
quartile had higher risk (HR 1.69, 95% CI 1.04-2.73) than those in the lowest quartile (HR 1.69, 95% 
1.04-2.73). (Appendix, Table 9b) No clear association were observed between serum PUFA and CVD in 
men.  
Serum cholesterol PUFA in relation to all-causes mortality 
EPA and DHA serum proportion were inversely associated with all-cause mortality in both men and 
women separately. LA was associated with decreased of all-cause mortality in men, but not in women 
(Table 8). Men in the highest LA quintile had 41 % lower mortality risk (HR 0.59; 95% CI 0.41-0.85) 
compared to those in the lowest quintile. (Appendix, Table 9a) ALA was not associated with all-cause 
mortality in both men and women. (Table 8) 
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Table 1: Baseline characteristics of 4,232 participants of the cohort of 60-year-old men and women. 
Characteristic 
 
All 
 
Men 
(n=2,039) 
Women 
(n=2,193) 
Physical activitya  (%) (m182) 30∙7 34∙6 27∙04 
Smoking (%) (m182):    
Never smoker 39∙8 33∙2 45∙98 
Ever smoker 60∙2 66∙8 54∙02 
Education (%) (m164):    
≤9years 59∙2 56∙6 61∙68 
9-12 years 13∙2 15∙4 11∙12 
> 12 years 27∙6 28∙0 27∙20 
Country of birth (%):    
Nordicb 89∙4 88∙3 90∙6 
Non Nordic 10∙6 11∙7 9∙53 
Anthropometric data    
BMI (Kg/m2) 
median (IQR) 
26∙32 (23∙91-29∙09) 26∙65 (24∙42-29∙07) 25∙96 (23∙43-29∙12) 
Waist circumference (cm) 
median (IQR)  (m3)  
92∙0 (83∙0-100∙0) 97∙0 (91∙0-104∙0) 85∙0 (78∙0-93∙0) 
WHR (m4) 
median (IQR) 
0∙89 (0∙81-0∙95) 0∙94 (0∙91-0∙99) 0∙82 (0∙78-0∙87) 
SAD (cm) 
median (IQR) (m7) 
20∙4 (18∙5-22∙5) 21∙3 (19∙5-23∙0) 19∙5 (17∙9-21∙4) 
Biological markers and blood pressure    
Insulin (µU/L) 
median (IQR)  (m4) 
8∙9 (6∙6-12∙4) 9∙3 (6∙8-13∙5) 8∙6 (6∙4-11∙7) 
Total cholesterol (mmol/L) 
median (IQR)  (m3) 
5∙9 (5∙3-6∙6) 5∙7 (5∙1 -6∙4) 6∙1 (5∙4-6∙8) 
HDL cholesterol (mmol/L) 
median (IQR) (m3) 
1∙44 ( 1∙19-1∙73) 1∙27 (1∙08-1∙5) 1∙61 (1∙36-1∙88) 
LDL cholesterol (mmol/L) (m64) 3∙8 (3∙2-4∙5) 3∙8 (3∙2-4∙4) 3∙9 (3∙3-4∙5) 
Triglycerides (mmol/L) 
median (IQR) (m3) 
1∙1 (0∙8-1∙6) 1∙2 (0∙9-1∙7) 1∙1 (0∙8-1∙5) 
Systolic BP (mmHg) 
median (IQR) (m5) 
136 (123-152) 141 (128-155) 132 (118-148) 
Diastolic BP 
median (IQR) (mmHg) (m5) 
84 (77-91) 87 (80-94) 81 (75-87) 
Metabolic factors    
Hypertensionc (%) (m5) 38∙2 46∙2 31∙0 
Hypercholesterolemiad (%) (m3) 35∙1 30∙7 39∙2 
Hypertriglyceridemiae (%) (m3) 8∙4 11∙2 5∙8 
Prediabetesf (%)(m3) 6∙1 8∙2 4∙1 
Diabetesg (%) (m3) 7∙5 10∙1 5∙2 
Obesity (BMI≥30) (%) 19∙6 18∙9 20∙2 
 
BMI, Body Mass Index; WHR, Waist to hip ratio; SAD, Sagittal abdominal diameter; BP, Blood pressure; m, missing value; IQR, 
interquartile range; aRegular physical activity in the leisure time; bNordic: Swedish and Finnish born; cSBP ≥140 mmHg, DBP≥90 
mmHg, self-reported hypertension or antihypertensive medication; dTotal cholesterol ≥6∙45 mmol/l, self-reported hyperlipedemia or 
use of lipid lowering drugs; eTriglycerides ≥2∙3 mmol/l; fAccording to WHO diagnostic criteria defined as fasting glucose levels in 
the range ≥6∙1 and ≤6∙9; gFasting serum glucose level ≥7∙0 mmol/l (WHO  cut-off), self-reported diabetes or anti-diabetic 
medication.  
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Table 2: Baseline characteristics between CVD and not CVD participants of the of 60-year-old men and women. 
 
 Men Women 
Characteristic 
 
CVD 
(n=306) 
NO CVD 
(n=1.445) 
CVD 
(n=185) 
NO CVD 
(n=1.805) 
Physical activitya  (%) (m48) 
32.4 35.8 20.56 28.56 
Smoking (%) (m48): 
    
Never smoker 
72 81 64.32 79.04 
Ever smoker 
27.8 18.6 35.68 20.96 
Education (%) (m32): 
    
≤9years 
60.8 55.4 73.09 60.34 
9-12 years 
16.0 15.2 7.17 11.58 
> 12 years 
23.2 29.3 19.73 28.08 
Country of birth (%): 
    
Nordicb (m5) 
 
89.2 88.4 94.05 91.18 
Non Nordic 
10.8 11.6 5.95 8.82 
Anthropometric data 
    
BMI (Kg/m2) 
median (IQR) 
26.9 (24.6-29.4) 26.4 (24.3-28.8) 27.1 (24.1-30) 26 (23-29) 
Waist circumference 
median (IQR)  
98 (91-103.5) 96.5 (90.5-103) 88.5 (80.5-96.5) 84.5 (77-92) 
WHR (m1) 
median (IQR) 
0.96 (0.92-0.99) 0.94 (0.91-0.98) 0.84 (0.80-0.90) 0.82 (0.77-0.86) 
SAD (cm) 
median (IQR) (m3) 
21.5 (19.8-23) 21 (19.5-23) 20.4 (18.5-22.5) 19.5 (17.8-21) 
Biological markers and blood pressure 
    
ApoA1 
median (IQR) (m7) 
1.38 (1.24-1.55) 1.42 (1.27-1.58) 1.6 (1.42-1.76) 1.62 (1.46-1.81) 
ApoB 
median (IQR) (m6) 
1.09(0.95-1.27) 1.04 (0.9-1.2) 1.1 (-0.94-1.28) 1.03 (0.89-1.2) 
ApoB/ApoA1  
median (IQR) (m7) 
1.25(1.02-1.5) 1.36 (1.12-1.65) 1.44 (1.14-1.72) 1.5 (1.3-1.9) 
Lp(a)  
median (IQR) (m2) 
0.13 (0.06-0.32) 0.11 (0.05-0.31) 0.13 (0.05-.38) 0.13 (0.06-0.35) 
Fibrinogen  
median (IQR) (m16) 
3.03(2.56-3.59) 2.8 (2.4-3.3) 3.14 (2.70-3.7) 2.9 (2.5-3.5) 
Uric acid(µmol/L)  
median (IQR) (m2) 
325 (287-370) 321 (284-366) 269 (232-307.5) 259 (224-299) 
Glucose  
median (IQR) (m2) 
5.4(5-6) 5.3 (5-5.8) 5.02 (4.8-5.8) 5.1 (4.7-5.5) 
Insulin (µU/L) 
median (IQR)  (m3) 
9.4 (7.3-14.4) 8.8 (6.5-12.8) 9.4 (6.6-12.7) 8.3 (6.2-11.3) 
Total cholesterol (mmol/L) 
median (IQR)  (m2) 
5.9 (5.2-6.6) 5.8 (5.1-6.4) 6.3 (5.5-6.9) 6.1 (5.4-6.8) 
HDL cholesterol (mmol/L) 
median (IQR) (m2) 
1.23 (1.02-1.5) 1.31 (1.1-1.53) 1.5 (1.26-1.78) 1.63 (1.39-1.9) 
LDL cholesterol (mmol/L) 
median (IQR) (m48) 
4 (3.4-4.6) 3.8 (3.2-4.4) 4 (3.3-4.6) 3.8 (3.2-4.5) 
Triglycerides (mmol/L) 
median (IQR) (m32) 
1.3 (0.9-1.8) 1.2 (0.8-1.6) 1.2 (0.9-1.7) 1.1 (0.8-1.4) 
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Systolic BP (mmHg) 
median (IQR) (m3) 
145.2(134-160.5) 140 (127-153.5) 141 (125.5-159) 130.5 (117-146) 
Diastolic BP (mmHg) 
median (IQR) (m3) 
89.5 (83.5-96) 86 (79.5-93) 84.5 (78-91) 80 (74-87) 
Metabolic factors 
    
Hypertensionc (%) (m1) 
54.6 40.2 41.62 28.14 
Hypercholesterolemiad (%) (m2) 
35 28.3 46.20 37.97 
Hypertriglyceridemiae (%) (m2) 
14.4 8.7 13.04 4.66 
Prediabetesf (%)(m32) 
13.4 7.3 9.24 3.44 
Diabetesg (%) (m2) 
14.38 7.5 11.41 3.88 
Obesity (BMI≥30) (%) 
20.9 16.6 25.41 18.28 
 
 
BMI, Body Mass Index; WHR, Waist to hip ratio; SAD, Sagittal abdominal diameter; BP, Blood pressure; m, missing value; IQR, 
interquartile range; aRegular physical activity in the leisure time; bNordic: Swedish and Finnish born; cSBP ≥140 mmHg, DBP≥90 
mmHg, self-reported hypertension or antihypertensive medication; dTotal cholesterol ≥6∙45 mmol/l, self-reported hyperlipedemia or 
use of lipid lowering drugs; eTriglycerides ≥2∙3 mmol/l; fAccording to WHO diagnostic criteria defined as fasting glucose levels in 
the range ≥6∙1 and ≤6∙9; gFasting serum glucose level ≥7∙0 mmol/l (WHO  cut-off), self-reported diabetes or anti-diabetic 
medication.  
 
Table 3: Percentiles (10th, 25th, 50th, 75th, and 90th) of serum cholesterol ester fatty acid distributions, expressed as 
proportions of the total fatty acid amount, in 4,150 participants of the cohort of 60-year-old men and women. 
 
 
 Percentile values of fatty acids (%) 
Fatty acid 10th 25th 50th 75th 90th 
14 : 0 0∙65 0∙76 0∙89 1∙02 1∙25 
15 : 0 0∙17 0∙19 0∙22 0∙25 0∙30 
16 : 0 10∙54 10∙92 11∙36 11∙86 12∙34 
18: 0 0∙62 0∙69 0∙76 0∙86 0∙96 
Tot. SFAa 12∙25 12∙70 13∙25 13∙86 14∙47 
16 : 1n-7 2∙26 2∙72 3∙40 4∙34 5∙54 
18 : 1 20∙52 21∙54 22∙59 23∙80 25∙05 
Tot. MUFAb 23∙15 24∙49 26∙09 28∙00 30∙15 
18 : 2n-6 43∙04 45∙90 48∙76 51∙21 53∙50 
18 :  n-6 0∙53 0∙67 0∙86 1∙09 1∙33 
20 : 3n-6 0∙54 0∙62 0∙71 0∙82 0∙92 
20 : 4n-6 4∙94 5∙52 6∙23 7∙01 7∙81 
18 :  3n-3 0∙64 0∙75 0∙86 1∙00 1∙13 
20 : 5n-3 1∙12 1∙44 1∙87 2∙46 3∙25 
22 : 6n-3 0∙62 0∙74 0∙89 1∙06 1∙24 
20 : 5n-3+22 :  6n-3 1∙81 2∙22 2∙75 3∙48 4∙42 
Tot. PUFA c 55∙98 58∙36 60∙61 62∙49 64∙10 
16 : 1n-7/16 : 0 0∙20 0∙24 0∙30 0∙38 0∙47 
 
aTotal SFA calculated as sum of all saturated fatty acids; bTotal MUFA calculated as sum of all monounsaturated fatty acids; cTotal 
PUFA calculated as sum of all polyunsaturated fatty acids.
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Table 4(a-e): Percentile differences with 95% confidence intervals, expressed as serum fatty acid proportions, at the 10th, 25th, 50th, 75th, and 90th percentile of serum 
cholesterol ester fatty acid distributions, across points of increase of diet score (Fishscore, Vegoilscore, Dairyscore, Satscore, Meatscore). Results based on 4,030 
participants of the cohort of 60-year-old men and women. 
 
Percentile differences of fatty acids (%) 
Fatty acid  10th 25th 50th 75th 90th 
(a) Fishscore 
20 : 5n-3 (EPA) 
Crude 22∙52 (19∙66, 25∙39) 27∙73 (24∙78, 30∙68) 33∙52 (29∙99, 37∙05) 45∙22 (39∙97, 50∙48) 57∙74 (47∙04, 68∙43) 
Adjusteda 21∙92 (18∙59, 25∙25) 27∙23 (24∙13, 30∙32) 33∙01 (29∙34, 36∙63) 44∙05 (38∙14, 49∙95) 54∙25 (44∙38, 64∙12) 
22 : 6n-3 (DHA) 
Crude 9∙33 (8∙16, 10∙50) 10∙72 (9∙63, 11∙81) 11∙57 (10∙49, 12∙66) 12∙36 (10∙94, 13∙78) 14∙61 (12∙60, 16∙62) 
Adjusteda 8∙70 (7∙43, 9∙98) 10∙32 (9∙19, 11∙44) 11∙11(9∙98, 12∙24) 11∙58 (10∙18, 12∙98) 14∙58 (12∙51, 16∙65) 
(b) Vegoilscore 
18 : 2n-6 
Crude 65∙27 (37∙82, 92∙72) 40∙04 (21∙38, 58∙71) 36∙30 (20∙30, 52∙30) 26∙43 (9∙87, 42∙98) 21∙13 (1∙29, 40∙97) 
Adjusteda 59∙88 (33∙58, 86∙18) 42∙46 (23∙96, 60∙96) 27∙60 (12∙55, 42∙64) 19∙61 (3∙21, 3∙60) 13∙98 (3∙08, 31∙04) 
18 : 3n-3 
Crude 0∙31 (1∙00, 1∙13) 0∙35(1∙11, 0∙41) 0∙14 (0∙90, 0∙61) 0∙28 (1∙29, 0∙73) 0∙63(0∙80, 2∙06) 
Adjusteda 0∙31 (1∙35, 0∙73) 0∙31(1∙09, 0∙47) 0∙18 (0∙98, 0∙61) 0∙22 (1∙17, 0∙73) 0∙31(1∙00, 1∙62) 
Tot. SFA 
Crude 6∙87 (11∙50, 2∙24) 7∙60 (10∙96, 4∙25) 7∙61 (10∙88, 4∙35) 9∙80 (14∙06, 5∙55) 14∙08 (19∙85, 8∙31) 
Adjusteda 6∙67 (11∙11, 2∙23) 8∙13 (11∙80, 4∙45) 8∙65 (12∙15, 5∙17) 11∙37 (15∙58, 7∙15) 12∙64 (18∙60 , 6∙67) 
Tot. PUFA 
Crude 61∙02 (34∙98, 87∙05) 46∙05 (29∙02, 63∙09) 28∙61 (17∙13, 40∙09) 28∙68 (16∙41, 40∙94) 26∙94 (11∙62, 42∙26) 
Adjusteda 57∙78 (35∙07, 80∙50) 48∙56 (33∙79, 63∙34) 28∙35 (15∙63, 41∙08) 20∙42 (8∙44, 32∙39) 22∙98 (8∙20, 37∙76) 
(c) Dairyscore 
14 : 0 
Crude 1∙54 (1∙15, 1∙91) 1∙ 37 (1∙01, 1∙72) 1∙09 (0∙76, 1∙42) 1∙10 (0∙73, 1∙47) 1∙34 (0∙80, 1∙99) 
Adjusteda 1∙33 (0∙91, 0∙18) 1∙31 (0∙95, 1∙68) 1∙10 (0∙74, 1∙46) 1∙13 (0∙73, 1∙53) 1∙29 (0∙67, 1∙92) 
15 : 0 
Crude 0∙28 (0∙19, 0∙37) 0∙30 (0∙22, 0∙37) 0∙26 (0∙19, 0∙34) 0∙29 (0∙20, 0∙39) 0∙35 (0∙21, 0∙48) 
Adjusteda 0∙28 (0∙17, 0∙38) 0∙31 (0∙25, 0∙38) 0∙29 (0∙21, 0∙36) 0∙34 (0∙25, 0∙42) 0∙38 (0∙24, 0∙52) 
16 : 0 
Crude 0∙87 (2∙48, 0∙74) 1∙84 (3∙16, 0∙52) 1∙47 (2∙73, 0∙21) 2∙78 (4∙33, 1∙23) 3∙80 (5∙80, 1∙80) 
Adjusteda 1∙53 (2∙93, 0∙12) 3∙03 (4∙33, 1∙73) 2∙84 (3∙94, 1∙73) 3∙44 (4∙98,  1∙89) 4∙21 ( 6, 2∙43) 
18 : 0 
Crude 0∙50 (0∙ 28, 0∙71) 0∙49 (0∙ 29, 0∙70) 0∙42 (0∙19, 0∙65) 0∙46 (0∙16, 0∙76) 0∙67 (0∙19, 1∙15) 
Adjusteda 0∙59 (0∙ 34, 0∙83) 0∙40 (0∙ 20, 0∙60) 0∙33 (0∙11, 0∙56) 0∙34 (0∙03, 0∙64) 0∙54 (0∙08, 1∙00) 
16 : 1n-7 
Crude 0∙33 (2∙01, 1∙34) 0∙44 (2∙35, 1∙46) 2∙85 (5∙00, 0∙70) 2∙79 (5∙87, 0∙27) 4∙74 (10∙09, 0∙60) 
Adjusteda 0∙19 (1∙68, 1∙30) 1∙10 (2∙79, 0∙60) 4∙07 (6∙18, 1∙96) 2∙39 (5∙53, 0∙73) 4∙03 (9∙17, 1∙11) 
18 : 1 
Crude 7∙11 (2∙68, 11∙54) 4∙69 (1∙69, 7∙68) 3∙21 (0∙12, 6∙29) 5∙34 (1∙69, 9∙00) 5∙95 (0∙17, 11∙72) 
Adjusteda 5∙48 (1∙45, 9∙51) 4∙28 (1∙03, 7∙53) 3∙77 (0∙57, 6∙98) 1∙63 (1∙97, 5∙23) 1∙01 (4∙22, 6∙24) 
16 : 1n-7/16 : 0 
Crude 0∙01 (0∙13, 0∙15) 0∙04 (0∙11, 0∙19) 0∙18 (0∙36, 0∙00) 0∙26 (0∙52, 0∙00) 0∙16 (0∙61, 0∙28) 
Adjusteda 0∙04 (0∙10, 0∙18) 0∙01 (0∙16, 0∙14) 0∙24 (0∙42, 0∙06) 0∙11 (0∙38, 0∙14) 0∙30 (0∙74, 0∙14) 
Tot. SFA 
Crude 1∙40 (0∙70, 3∙49) 0∙12 (1∙33, 1∙58) 0∙08 (1∙38, 1∙54) 0∙04 (1∙82, 1∙90) 2∙03 (4∙50, 0∙44) 
Adjusteda 0∙44 (1∙52, 2∙41) 0∙46 (2∙17, 1∙25)  1∙38 (2∙88, 0∙11)  1∙39 (3∙34, 0∙57) 3∙11 (5∙91, 0∙32) 
Tot. MUFA 
Crude 2∙68 (∙2∙42, 7∙78) 3∙20 (0∙95, 7∙36) 2∙09 (2∙61, 6∙80) 1∙64 (7∙12, 14∙08) 3∙48 (7∙12, 14∙08) 
Adjusteda 1∙26 (4∙09, 6∙60) 2∙60 (2∙21, 7∙42) 0∙54 (3∙89, 4∙98) 0∙38 (5∙63, 6∙40) 5∙17 (14∙62, 4∙28) 
(d) Satscore 
14 : 0 
Crude 0∙80 (0∙48, 1∙12) 0∙64 (0∙37, 0∙92) 0∙38 (0∙13, 0∙64) 0∙38 (0∙13, 0∙67) 0∙65 (0∙21, 1∙10) 
Adjusteda 0∙64 (0∙35, 0∙93) 0∙57 (0∙29, 0∙86) 0∙31 (0∙05, 0∙58) 0∙36 (0∙04, 0∙68) 0∙55 (0∙06, 1∙04) 
15 : 0 
Crude 0∙10 (0∙04, 0∙17) 0∙13 (0∙07, 0∙19) 0∙13 (0∙07, 0∙18) 0∙17 (0∙09, 0∙24) 0∙16 (0∙06, 0∙27) 
Adjusteda 0∙10 (0∙03, 0∙17) 0∙13 (0∙08, 0∙19) 0∙13 (0∙07, 0∙20) 0∙19 (0∙12, 0∙26) 0∙20 (0∙09, 0∙31) 
 
Crude 0∙08 (1∙29, 1∙29) 0∙47 (1∙49, 0∙53) 0∙69 (1∙64, 0∙26) 1∙75 (2∙91, 0∙58) 2∙26 (3∙83, 0∙90) 
16 : 0 Adjusteda 0∙91 (2∙05, 0∙23) 2∙13 (3∙11, 1∙14) 2∙15 (3∙06, 1∙24) 2∙76 (3∙98, 1∙55) 3∙30 (4∙67, 1∙93) 
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Crude 0∙40 (0∙24, 0∙56) 0∙46 (0∙30, 0∙61) 0∙43 (0∙26, 0∙60) 0∙49 (0∙26, 0∙73) 0∙57 (0∙19, 0∙95) 
18 : 0 Adjusteda 0∙39 (0∙20, 0∙57) 0∙33 (0∙18, 0∙48) 0∙25 (0∙08, 0∙43) 0∙31 (0∙08, 0∙55) 0∙45 (0∙08, 0∙82) 
16 : 1n-7 
Crude 0∙79 (2∙08, 0∙49) 1∙52 (2∙95, 0∙10) 3∙30 (4∙88, 1∙73) 2∙89 (5∙24, 0∙54) 3∙56 (7∙66, 0∙53) 
Adjusteda 0∙31 (1∙47, 0∙85) 1∙25 (2∙59, 0∙09) 3∙33 (4∙92, 1∙74) 1∙76 (4∙21, 0∙68) 3∙30 (7∙42, 0∙82) 
18 : 1 
Crude 5∙10 (1∙70, 8∙50) 3∙22 (0∙97, 5∙47) 2∙21 (0∙17, 4∙60) 4∙56 (1∙76, 7∙37) 4∙85 (0∙43, 9∙26) 
Adjusteda 3∙35 (0∙21, 6∙49) 2∙92 (0∙35, 5∙50) 2∙33 (0∙80, 4∙83) 1∙15 (2∙97, 5∙27) 12∙97 (22∙07, 3∙87) 
16 : 1n-7/16 : 0 
Crude 0∙05 (0∙15, 0∙06)  0∙08 (0∙19, 0∙04) 0∙25 (0∙38, 0∙11) 0∙22 (0∙4 2, 0∙02) 0∙22 (0∙57, 0∙11) 
Adjusteda 0∙00 (0∙11, 0∙10) 0∙04 (0∙15, 0∙09) 0∙22 (0∙37, 0∙08) 0∙09 (-0∙29, 0∙11) 0∙21 (0∙55, 0∙14) 
Tot. SFA 
Crude 1∙78 (0∙20, 3∙26) 0∙30 (0∙80, 1∙40) 0∙21 (1∙14, 1∙56) 1∙23 (3∙04, 0∙58) 1∙23 (3∙04, 0∙59) 
Adjusteda 0∙24 (1∙24, 1∙71) 0∙65 (1∙94, 0∙64) 1∙33 (2∙51, 0∙15) 1∙95 (3∙45, 0∙45) 3∙48 (5∙67, 1∙30) 
Tot. MUFA 
Crude 1∙64 (2∙21, 5∙49) 1∙37 (1∙75, 4∙50) 0∙06 (3∙57, 3∙45) 0∙44 (5∙02, 4∙14) 2∙13 (5∙76, 10∙03) 
Adjusteda 0∙01 (3∙97, 3∙95) 0∙44 (3∙20, 4∙09) 1∙34 (4∙67, 2∙00) 0∙93 (5∙46, 3∙59) 4∙75 (12∙13, 2∙64) 
e) Meatscore 
14 : 0 
Crude 0∙63 (1∙30, 0∙03) 0∙79 (1∙38, 0∙20) 0∙90 (0∙15, 0∙32) 0∙94 (1∙59, 0∙29) 0∙86 (1∙96, 0∙24) 
Adjusteda 0∙94 ( 1∙61, 0∙26) 1∙13 (1∙78, 0∙48) 1∙31 (1∙88, 0∙74) 1∙42 (2∙10, 0∙74) 1∙34 (2∙40, 0∙28) 
15 : 0 
Crude 0∙17 (0∙32, 0∙02) 0∙20 (0∙32, 0∙08) 0∙17 (0∙29, 0∙05) 0∙09 (0∙25, 0∙07) 0∙01 (0∙26, 0∙23) 
Adjusteda 0∙20 (0∙35, 0∙06) 0∙23 (0∙37, 0∙10) 0∙22 (0∙35, 0∙08) 0∙17 (0∙34, 0∙02) 0∙15 (0∙38, 0∙08) 
16 : 0 
Crude 3∙56 (1∙07, 6∙04) 2∙36 (0∙13, 4∙59) 2∙04 (0∙13, 4∙20) 0∙18 (2∙39, 2∙74) 1∙40 (5∙04, 2∙23) 
Adjusteda 0∙37 (2∙30, 3∙04) 1∙73 (4∙04, 0∙57) 0∙19 (3∙87, 0∙10) 4∙31 (7∙01, 1∙61) 3∙69 (6∙67, 0∙72) 
18 : 0 
Crude 0∙68 (0∙31, 1∙04) 0∙85 (0∙51, 1∙18) 0∙83 (0∙46, 1∙20) 1∙11 (0∙60, 1∙61) 0∙82 (0∙00, 1∙64) 
Adjusteda 0∙46 (0∙01, 0∙91) 0∙44 (0∙11, 0∙78) 0∙36 (0∙03, 0∙75) 0∙54 (0∙02, 1∙06) 0∙39 ( 0∙48, 1∙27) 
16 : 1n-7 
Crude 2∙53 (5∙30, 0∙23) 5∙23 (8∙36, 2∙1) 7∙34 (10∙91, 3∙77) 6∙51 (11∙79, 1∙23) 8∙30 (17∙85, 1∙25) 
Adjusteda 0∙95 (3∙50, 1∙60) 2∙76 (5∙70, 0∙18) 5∙29 (8∙90, 1∙67) 2∙83 (8∙12, 2∙46) 6∙55 (15∙42, 2∙33) 
18 : 1 
Crude 2∙95 (4∙89, 10∙79) 3∙49 (1∙51, 8∙48) 3∙70 (1∙55, 8∙95) 6∙19 (0∙12, 12∙26) 4∙00 (5∙16, 13∙16) 
Adjusteda 4∙91 (1∙68, 11∙51) 3∙61 (2∙24, 9∙46) 1∙52 (4∙10, 7∙14) 2∙89 (3∙55, 9∙34) 2∙97 (6∙26, 12∙22) 
16 : 1n-7/16 : 0 
Crude 0∙27 (0∙52, 0∙02) 0∙45 (0∙71, 0∙19) 0∙66 (0∙95, 0∙37) 0∙57 (0∙98,  0∙15) 0∙70 (1∙42, 0∙01) 
Adjusteda  0∙10 (0∙35, 0∙14) 0∙17 (0∙43, 0∙08) 0∙35 ( 0∙67, 0∙03) 0∙16 (0∙61, 0∙29)  0∙24 (1∙03, 0∙05) 
Tot. SFA 
Crude 3∙75 (0∙43, 7∙08) 1∙32 (1∙12, 3∙76) 0∙83 (1∙65, 3∙30) 0∙97 (2∙05, 3∙98)  1∙32 (5∙54, 2∙90) 
Adjusteda 0∙68 (3∙97, 2∙61) 2∙30 (5∙15, 0∙54) 2∙84 (5∙50, 0∙19) 4∙75 (8∙18, 1∙32) 7∙63 (12∙34, 2∙92) 
Tot. MUFA 
Crude 1∙17 (7∙41, 9∙76)  3∙07 (9∙87, 3∙73)  4∙67 (12∙24, 2∙90) 4∙47 (14∙62, 5∙68) 3∙14 (13∙86, 20∙15) 
Adjusteda 0∙02 (8∙94, 8∙99) 0∙06 (8∙12, 8∙00) 5∙18 (13∙46, 3∙10) 2∙47 (13∙03, 8∙09) 3∙75 (20∙06, 12∙56) 
To improve the readability of percentile differences presented, values were multiplied by 100. aModel adjusted for sex, physical activity, and smoking. 
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Fig. 12 (a) (b) (c) (d): The lines describe the predicted increase or decrease of serum cholesterol fatty acids proportion at the 10th, 25th, 50th, 75th, and 90th fatty acid 
percentile, based on a model adjusted for sex, physical activity, and smoking status using the median of each covariate for each point’s increase of the diet score. (a) 
Predicted increase of serum cholesterol 20:5 n-3 proportion for each point’s increase of Fishscore; (b) Predicted increase of serum cholesterol 22:6 n-3 proportion for each 
point’s increase of Fishscore; (c) Predicted increase of serum cholesterol total PUFA proportion for each point’s increase of Vegoilscore; (d) Predicted decrease of serum 
cholesterol total SFA proportion for each point’s increase of Vegoilscore. 
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Table 5: Hazard ratios (HR) and 95% confidence intervals (CI) for incidence of cardiovascular disease (CVD) and all-causes of mortality in relation to diet scores. Results based on 
participants of the cohort of 60-year-old men and women. 
  
  Incident CVD All-cause mortality Incident CVD All-cause mortality 
  Men Women 
Dietscore  HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) 
Fishscore cont1      
Crude  0.95 (0.81-1.10) 1.05 (0.92-1.21) 0.90 (0.74-1.09) 0.86 (0.72-1.03) 
Adjusted2  0.96 (0.82-1.12) 1.10 (0.95-1.28) 1.02 (0.84-1.25) 0.95 (0.79 - 1.14) 
Vegoilscore cont1      
Crude  0.99 (0.88 - 1.12) 0.87(0.78-0.97) 1.09 (0.93 - 1.27) 1.04 (0.90 - 1.19) 
Adjusted2  1.03 (0.91 - 1.16) 0.93 (0.82 - 1.04) 1.12 (0.96 - 1.31) 1.06 (0.92 - 1.23) 
Dairyscore cont1      
Crude  1.01 (0.96 - 1.06) 1.08 (1.08-1.14) 1.05 (0.98 - 1.12) 1.08 (1.02-1.15) 
Adjusted1  0.97 (0.92 - 1.03) 1.03 (0.97 - 1.08) 1.00 (0.93 - 1.08) 1.02 (0.95 - 1.09) 
Satscore cont1      
Crude  1.01 (0.97-1.05) 1.07 (1.03-1.11) 1.05 (0.99 - 1.11) 1.06 (1.01-1.11) 
Adjusted2  0.98 (0.94 - 1.02) 1.03 (0.99-1.07) 1.01 (0.95 - 1.07) 1.01 (0.96 - 1.06) 
      
Meatscore cont1      
Crude  1.03 (0.95 - 1.12) 1.11 (1.03 - 1.20) 1.11 (0.98 - 1.25) 1.04 (0.93 - 1.17) 
Adjusted2  0.98 (0.90 - 1.07) 1.05 (0.97 - 1.14) 1.05 (0.92 - 1.19) 0.99 (0.88 - 1.11) 
 
1diet score used as continuous variable 2model adjusted for smoking, physical activity and education 
 
 
Table 6: Hazard ratios (HR) 95% confidence intervals (CI) for incidence of cardiovascular disease (CVD) and all-cause mortality in relation to specific foods intake. Results based on 
participants of the cohort of 60-year-old men and women. 
 
 
Variables 
Incident CVD 
 
All-cause mortality 
 
Incident CVD 
 
All-cause mortality 
 
 Men Women 
 HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) 
<1/week lean fish Ref Ref Ref Ref 
≥1/week 0.88 (0.70-1.11) 1.03 (0.82-1.29) 0.84 (0.62-1.14) 0.75 (0.57-0.98) 
Adjusted1 0.85 (0.67-1.07) 1.06 (0.84-1.33) 1.00 (0.73-1.37) 0.85 (0.64-1.12) 
<1/week fatty fish Ref Ref Ref Ref 
≥1/week 1.00 (0.77-1.29) 1.10 (0.87-1.40) 0.96 (0.68-1.34) 0.88 (0.65-1.21) 
Adjusted1 1.06 (0.81-1.39) 1.19 (0.93-1.53) 1.11 (0.79-1.56) 1.02 (0.74-1.40) 
≤2 slices of bread/day Ref. Ref. Ref. Ref. 
≥3/day 0.85 (0.68-1.07) 1.04 (0.83-1.29) 0.90 (0.67-1.20) 1.02 (0.78-1.33) 
Adjusted1 0.88 (0.70-1.11) 1.13 (0.90-1.41) 0.92 (0.68-1.24) 1.08 (0.82-1.41) 
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Margarines (for sandwiches) Ref. Ref. Ref. Ref. 
Butter 1.07 (0.84-1.37) 1.36 (1.09 - 1.71) 0.85 (0.61-1.19) 1.05 (0.79-1.40) 
Adjusted1 1.05 (0.81-1.35) 1.28 (1.01-1.62) 0.83 (0.59-1.16) 1.05 (0.79-1.41) 
<10g Butter/Margarine Ref. Ref. Ref. Ref. 
≥10g Butter/Margarine 1.14 (0.87-1.50) 1.85 (1.47-2.34) 1.72 (1.18-2.49) 1.11 (0.77-1.61) 
Adjusted1 1.04 (0.78-1.38) 1.57(1.23-2.02) 1.49 (1.02-2.20) 0.98 (0.67-1.43) 
≤1 Cheese slices Ref. Ref. Ref. Ref. 
≥2 1.02 (0.81-1.30) 1.11 (0.88-1.39) 0.87 (0.65-1.16) 1.05 (0.80-1.38) 
Adjusted1 0.98 (0.76-1.24) 1.00 (0.79-1.26) 0.86 (0.64-1.16) 0.94 (0.72-1.24) 
Light milkfat- or no milk products Ref. Ref. Ref. Ref. 
Standard milk (3%) 1.03 (0.82-1.29) 1.10 (0.88-1.36) 1.05 (0.79-1.40) 1.31 (1.01-1.71) 
Adjusted1 0.97 (0.77-1.23) 0.95 (0.77-1.19) 0.96 (0.71-1.29) 1.17 (0.90-1.53) 
<1times/week sausages/bacon  Ref. Ref. Ref. Ref. 
≥1times/week 1.07 (0.85-1.34) 1.29 (1.04-1.60) 1.30 (0.96-1.77) 1.21 (0.91-1.60) 
Adjusted1 1.01 (0.80-1.28) 1.18 (0.94-1.47) 1.15 (0.83-1.57) 1.11 (0.83-1.48) 
No meatfat Ref. Ref. Ref. Ref. 
Meatfat 1.09 (0.87-1.36) 1.07 (0.86-1.32) 1.23 (0.89-1.71) 1.20 (0.89-1.61) 
Adjusted1 1.03 (0.82-1.30) 0.97 (0.78-1.21) 1.15 (0.82-1.60) 1.11 (0.81-1.49) 
≤1times/week Oily potatoes2 Ref Ref. Ref. Ref. 
≥2times/week 1.03 (0.74-1.42) 1.27 (0.95-1.69) 2.00 (1.11-3.59) 1.51 (0.85-2.71) 
Adjusted1 1.02 (0.73-1.42) 1.14 (0.85-1.54) 2.00 (1.11-3.60) 1.49 (0.84-2.68) 
<4 eggs /week Ref. Ref. Ref. Ref. 
≥4times/week 0.98 (0.69-1.38) 1.66 (1.27-2.18) 0.97 (0.59-1.60) 1.03 (0.66-1.60) 
Adjusted1 0.90 (0.63-1.30) 1.53 (1.15-2.02) 0.84 (0.50-1.41) 0.90 (0.57-1.41) 
Panfry margarines or oil Ref. Ref. Ref. Ref. 
Butter 1.09 (0.82-1.46) 1.31 (1.00-1.70) 0.96 (0.65-1.40) 0.84 (0.58-1.22) 
Adjusted1 1.01 (0.75-1.37) 1.19 (0.91-1.57) 0.89 (0.60-1.32) 0.79 (0.54-1.15) 
≤1times/week Cream3 Ref. Ref. Ref. Ref. 
≥2times/week 0.75 (0.51-1.10) 1.12 (0.81-1.54) 1.09 (0.69-1.74) 0.75 (0.46-1.24) 
Adjusted1 0.69 (0.47-1.03) 0.99 (0.71-1.38) 1.04 (0.64-1.67) 0.68 (0.41-1.13) 
≤1times/week Desserts4 Ref. Ref. Ref. Ref. 
≥2times/week 0.88 (0.64-1.21) 0.96 (0.71-1.29) 0.88 (0.58-1.34) 0.97 (0.66-1.40) 
Adjusted1 0.91 (0.65-1.26) 1.03 (0.76-1.40) 1.00 (0.65-1.51) 1.01 (0.69 - 1.48) 
1 Adjusted for smoking, physical activity and education  2including pan-fried potato, French fries and potatoes au gratin; 3including sour cream, crème fraiche and sauces; 4including potato chips, chocolate, 
croissants, Danish pastries, cakes and cheeses.  
 
 
Table 7: Hazard ratios (HR) 95% confidence intervals (CI) for incidence of cardiovascular disease (CVD) and all-cause mortality in relation to self-reported intake of vegetables and 
fruits.  Results based on participants of the cohort of 60-year-old men and women. 
 
 
Diet 
Variables 
Incident CVD 
 
All-cause mortality 
 
Incident CVD 
 
All-cause mortality 
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 Men Women 
 HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) 
<1/day fruits/berries Ref Ref Ref Ref 
≥1times/day 0.73 (0.58-0.91) 0.63 (0.50-0.78) 0.66 (0.48-0.90) 0.62 (0.47-0.82) 
Adjusted1 0.83(0.66-1.05) 0.75 (0.60-0.94) 0.80 (0.58-1.11) 0.83 (0.62-1.11) 
<1/day vegetables2/roots/tubers Ref Ref Ref Ref 
≥1times/day 0.83 (0.66-1.04) 0.70 (0.57-0.87) 0.83 (0.61-1.13) 0.73 (0.55-0.96) 
Adjusted1 0.94 (0.74-1.19) 0.81(0.64-1.01) 0.98 (0.71-1.35) 0.90 (0.67-1.19) 
1Model adjusted for education, smoking and physical activity; 2 except for lettuce, cucumber and tomatoes 
 
 
 
Table 8: Hazard ratios and 95% of confidence interval for incident of cardiovascular disease (CVD) and all-cause mortality in relation to serum PUFA. Results based on participants of 
the cohort of 60-year-old men and women. 
 
    Men (n=1733) Women (n=1938) 
Incident CVD Events (person-years)   304 (22,274) 180 (26,469) 
 Hazard ratio (95% CI)1 EPA Crude 0.99 (0.88, 1.12) 0.78 (0.64, 0.96) 
   Adjusted2 1.02 (0.90, 1.16) 0.79 (0.64, 0.97) 
  DHA Crude 0.93 (0.83, 1.05) 0.70 (0.59, 0.84) 
   Adjusted 0.96 (0.85, 1.09) 0.74 (0.61, 0.89) 
  LA  Crude 0.88 (0.78, 0.99) 0.94 (0.80, 1.09) 
   Adjusted1 0.90 (0.79, 1.03) 0.99 (0.84, 1.18) 
  ALA Crude 0.99 (0.88, 1.11) 1.15 (1.01, 1.31) 
   Adjusted1 1.02 (0.91, 1.14) 1.16 (1.02, 1.32) 
      
Total mortality Deaths (person-years)   265 (23,917) 191 (27,418) 
 Hazard ratio (95% CI) EPA Crude 0.79 (0.69, 0.91) 0.78 (0.65, 0.94) 
   Adjusted1 0.82 (0.71, 0.95) 0.79 (0.65, 0.96) 
  DHA Crude 0.78 (0.68, 0.89) 0.75 (0.63, 0.89) 
   Adjusted1 0.82 (0.71, 0.94) 0.78 (0.66, 0.93) 
  LA  Crude 0.73 (0.65, 0.83) 0.93 (0.80, 1.07) 
   Adjusted1 0.73 (0.64, 0.83) 0.95 (0.81, 1.12) 
  ALA Crude 1.10 (0.98, 1.23) 0.99 (0.87, 1.13) 
   Adjusted1 1.10 (0.99, 1.22) 0.98 (0.86, 1.12) 
ALA, α-linolenic acid; EPA, ;DHA, ; LA, ; CVD, cardiovascular disease;  
1Per 1 SD increment: LA (women, 4.09%; men, 4.20%; total, 4.14%), ALA (women, 0.20%; men, 0.20%;  total, 0.20%), EPA (women, 1.02%; men, 0.95%;  total, 0.99%), 
DHA (women, 0.24%; men, 0.25%;  total, 0.25%).  
2Adjusted for sex (only in analyses of the total study population), BMI, smoking, physical activity, education, alcohol intake, diabetes, hypertension, hypercholesterolemia. 
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DISCUSSION 
Paper I 
Relation self-reported dietary fat and serum cholesterol fatty acids  
In this large population-based cohort of 60-year-old Swedish men and women, high intake of lean and 
fatty fish (Fishscore), was associated with high serum proportions of EPA and DHA. Moreover, a high 
intake of vegetable oils and margarines (Vegoilscore) was associated positively to serum proportions of 
total PUFA and negatively to serum proportions of total SFA. Intake of fats from dairy products 
(Dairyscore) and intake of saturated fats in general (Satscore) was associated slightly with specific SFA, 
but intake of processed meat and eggs (Meatscore) was not.  
As in previous studies, a clear relation between fish intake and EPA and DHA was noted
50,54,56,62,70,102,103
.  
Only in a few investigations, all of them with a sample size less than 1,320 subjects, the observed 
associations were less clear 
49,103-105
.  To the best of our knowledge, our study is the first study on the 
relation between fish intake and fatty acids performed in a Nordic general population of more than 4,000 
subjects. Our results suggest that for 60-year-old individuals, regardless of their individual fatty acid 
profile in terms of proportion for EPA and DHA, the amount of fish intake may affect serum levels of 
EPA and DHA, fatty acids that are associated with CVD risk and other chronic diseases
106
. We found that 
the association between Fishscore and EPA and DHA was more pronounced in men than in women. The 
results of an earlier study on a cohort of 4,949 British 64-year-old men and women, however, showed the 
opposite
107
. In both studies, the frequencies of fish intake were similar in men and women, and the overall 
proportions of serum EPA and DHA were slightly higher in women than in men. The discrepancy of the 
results might be related to differences in cooking methods or different distributions of unmeasured factors 
in the two populations that affect the biological response to fish intake.  
Our findings of an association between Vegoilscore and increased total PUFA and decreased total SFA in 
serum are in line with the results reported from a Finnish study that included 1,033 men and which used a 
similar approach as we did to categorize fat intake. The Finnish study also observed that spread and 
cooking fats with high content of PUFA were negatively associated with myristic acid and positively 
associated with linoleic acid measured in erythrocytes
56
. Our finding that there is no clear association 
between Vegoilscore and linoleic acids in the upper percentile of the linoleic acid distribution after 
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adjustments needs confirmation. The Finnish study observed a positive association between spread and 
cooking fats and alfa-linolenic acid, but our study found no such association. The different results may 
relate to the fact that different populations may use different amounts of spread and cooking fats (i.e., 
alfa-linolenic acid intake may differ). Studies that considered margarines and vegetable oils separately 
have shown positive associations between margarines and linoleic acids
63
 but a negative association 
between vegetable oils and alfa-linolenic acid
62
.    
The slight positive associations between Dairyscore and myristic acid and pentadecanoic acid found in 
our study are consistent with findings from previous investigations performed in Scandinavian 
countries
56,57,59,60,102
, and in three large cohorts in Europe and Australia (each including around 4,000 
subjects)
62,63,69
. Our finding of a slight positive association between Dairyscore and serum proportion of 
stearic acid disagrees with the findings reported in two large European cohort studies, where the 
associations tended to be reversed
62,69
.  
Our results of slightly higher serum proportion of myristic acid and stearic acid in relation to Satscore 
agree with results from two studies performed in Finland
54,56
. One of these studies, which included 84 
men and women, observed an association with serum proportion of palmitic acid as well
54
. The other 
study, including 1,033 men, studied only myristic acid (measured in erythrocytes) and found an 
association
56
. No previous study has investigated the intake of saturated fat in general in relation to 
pentadecanoic acid, a relation that our study found. 
In our study the lack of association observed between Meatscore and specific serum fatty acids might be 
related to the endogenous synthesis of the even-numbered carbon chain of SFA and MUFA.  
Project II 
Relation self-reported dietary fat and risk of incidence of CVD and all-causes mortality  
In this cohort of 60 years old men and women, high self-reported intake of specific group of fats - fats 
from food rich in saturated, fats from dairy, fish, animal products and vegetables oils and margarine -  
was not predictive of incidence of CVD and all-causes mortality.  However, with regard to sex-specific 
relation single specific foods rich in fat were better predictors of incidence of CVD, including MI, stoke, 
and total mortality. Consumption of more than 10g/day of butter and margarine increase CVD incidence 
in women and all-causes mortality in men. Intake of more than 2 times per week of “oily” potato (pan-
fried potatoes, French fries or potato au gratin) increased CVD incidence in women where consumption 
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of spread butter (instead of margarine) and intake of eggs more than 4 times per week were associated 
with increase total mortality in men. Daily intake of fruits but not vegetables was protective on all-causes 
mortality in only men. 
Our finding of no association of self-reported intake of food rich in saturated fats (Satscore) and incidence 
of CVD, including stroke and MI, and all-causes mortality in both men and women is generally consistent 
with findings reported in other epidemiological studies
78,80,108,109
. However, our findings are in contrast 
with those earlier prospective studies reporting clear increased or decreased risk of CVD and total 
mortality in relation to intake of saturated fat intake
78
.  Compare to our investigation, these different 
results might be related to the fact that most of these studies found an association between saturated fat 
intake and CVD and all-causes mortality in specific subset of the study populations with a small number 
of cases -i.e younger versus older, women v men and for some CHD endpoint-
78,80
.  
Concerning our findings of no clear association of saturated fat from dairy (Dairyscore) and meat product 
(Meatscore) and incidence of CVD and all-causes mortality, earlier epidemiological studies reported no 
association where some other studies reported a protection or harmful effect on CVD and total 
mortality
83,84
. However, these different results might be referred to several factors: wide spectrum of dairy 
and meat products available on the market with diverse nutritional characteristics, unrepresentative 
population and different nutritional methods used for the assessment, amount of fats diverse across 
populations.  
Our no significant protection of fats from fish and CVD and all-causes mortality in both men and women 
are confirmed in some previous large prospective studies but in contrast with results from meta-analysis 
and other epidemiological studies across different countries
93,110,111
. These discrepancies might be 
explained by differences across populations in cooking methods fish, kind of fish, presence of 
contaminants as mercury or PBC that might increase the incidence of CVD and mortality. These 
differences might also explained the reason because in other Nordic studies a lack of clear protection of 
fish intake and incidence of CVD and all-causes mortality have been shown
112-114
.  
Our results of no clear association between high intake of vegetables oils, margarines and CVD and all-
causes mortality is consistence with some epidemiological studies but not with others
115,116
. Differences in 
the results might be related to different source of PUFA across populations as well foods that goes with 
these vegetables oils and margarine.    
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Only few studies have considered the association between fat intake from specific foods intake and 
incidence of CVD and all-causes mortality, considering also sex-specific relations
82
. Our finding about 
association between a specific consumption of more than 10g/day of butter and margarine and CVD in 
women is in line to some extent with one previous large Swedish cohort study of only women
117
. As in 
our study, in this investigation the authors found a specific association between butter used to spread (and 
not for cooking) and MI in women. Opposite to our results of increased total mortality in relation to 
intake of butter, in a large Dutch cohort of men and women no association were noted in men for intake 
of butter and total mortality where a slight increase risk of CHD was noted for women
108
.  
To our knowledge, no previous studies have reported a specific association between “oily potato” 
including French fries or potato au gratin and incidence of CVD. However, evidences from studies 
investigating the association between fried food and cream and CVD (and total mortality) are 
controversial reporting no association and increased risk
83,118
 . 
Several studies have investigated the relation between eggs intake and incidence of CVD, MI and stroke, 
and CVD mortality whereas the association with all-causes mortality is limited to few studies
86-89
. Our 
finding of increased total mortality and intake of eggs more than 4 times per week in only men agree with 
the results found in a large cohort study observing physician men (21,327) 
87
. But in two other large 
cohorts of men no association between intake of 1 eggs per day and MI, CVD mortality and all-causes 
mortality have been reported
88,89
. However, these results should be interpret with caution and need further 
investigations to understand how is the relation with specific cause of mortality. 
Our results of a protective association of daily fruit intake for total mortality in men are generally 
consistent with other previous studies
94,119,120
. As in our study, in the Kuopio Ischemic Heart Disease risk 
factors (KIHD) study, the middle-aged Finnish men were noted to have reduced risk of mortality with 
daily fruits, berries and vegetables
120
. On the other hand, our finding about no clear protection for daily 
intake of vegetables and CVD and all-causes mortality might be depend on the process and the method of 
cooking vegetables that it might affect healthy components of vegetables - antioxidant and vitamins-. This 
might be strength by studies that found a lower risk in CVD and mortality in relation to intake of raw 
vegetables compared to the cooked
121
. 
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Findings from this cohort study suggest that considering fats, and in specific saturated fats as 
heterogeneous group might hide some specific associations between diet and incidence of CVD and all-
causes mortality.  
If the sex-specific associations between single questions were to be causal we can speculate that it might 
have been for sex-specific effects of some protective or harmful components in butter, oily potatoes, fruits 
on the potential intermediate factors (e.g. blood lipids, fatty acids, glucose, hormones) involved in the 
atherosclerotic process of CVD,  and in the induction of all-causes mortality
122
. For instance, as shown in 
our Project III, sex specific association between serum PUFA and CVD and total mortality was noted. 
Moreover, our results of an association of single specific food and CVD in women and total mortality in 
men might suggest that maybe similar foods might have a non-fatal prediction for women and fatal for 
men. Also the interactions between nutritional components, environmental factors and genes may explain 
the gender differences
123
.   
 
Dairy products are important contributors to saturated fatty acids in Sweden
38,41
. Butter, cream (potatoes 
au gratin) are rich in saturated fatty acids, fried food (French fries) in trans fatty acids and margarine are 
important source of PUFA, linoleic and alfa linolenic acid nowadays (where 15-20 years ago were rich in 
trans fatty acids). Generally, there is evidence that saturated and trans fatty acids are related to CVD and 
mortality intake through an increase in LDL cholesterol where LA and ALA might reduce LDL 
cholesterol, blood pressure and promote insulin sensitivity
96,97
. In our study we did not find a significant 
association between reported quantity of butter or oily potatoes with cholesterol lipids; at the baseline, 
among those reporting a high intake of butter we noted a modification in triglycerides in women (data not 
shown). Moreover, we can not exclude that these associations regarding spread butter and margarine, 
“oily potato” and CVD might be confounded by intake of carbohydrate source as bread for spread butter 
and margarine and potato for the oily potato (that it was not possible to calculate).  
 
Eggs are the major source of cholesterol but even other nutrient, mineral and folate, B vitamins, 
proteins
124
.  Previous studies have reported an increased mortality in diabetic subjects in relation to intake 
of eggs
86
. However, adjustment for metabolic factors including diabetes does not explain these 
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associations. We might think that high eggs intake affect metabolic factors that might enhance the 
induction of tumors more than the atherosclerosis process
125
.  
 
Fruits and vegetable are composed by different protective components such as potassium, folate, 
vitamins, fibers and other phenolic compounds
126
. These nutrients act through a variety of potential 
mechanisms, such as reduction of antioxidant stress, improvement of lipoprotein profile, lowering of 
blood pressure, increase of insulin sensitivity and improvement of hemostasis regulation
127,128
. 
Still our findings suggest that the associations between diet and CVD are not independent. But as shown 
for the most our results the association is dependent by lifestyle factors -smoking and physical activity- 
and education. Some previous study have showed the importance to change lifestyle –smoke cessation or 
increasing physical activity- is better prevention than only have an healthy diet based on reduced 
saturated fat intake. 
 
Project III 
Relation serum cholesterol PUFA and risk of incidence of CVD and all-causes mortality  
In our study, we found a sex-specific association between selected serum PUFA and incidence of CVD 
and total mortality. N-3 serum EPA and DHA were associated with decreased risk of incidence of CVD 
in women and mortality in both gender. Serum ALA was associated with increased risk of incidence of 
CVD in only women where serum LA was associated to decreased risk total mortality in men. To our 
knowledge, this is one of the largest population-based prospective cohort study with mortality data and 
equal proportions of men and women, addressing incidence of CVD and all-causes mortality in relation to 
selected serum FA.   
The observed discrepancies between men and women regarding protective effects of EPA and DHA on 
CVD, are confirmed in a recent meta-analysis where the authors have reported no associations between n-
3 PUFA and incidence CVD in men
90
. This sex-specific differences in the investigated association might 
not explained by differences in fish intake, as found in Project I in the same population. However, a 
greater proportion of serum DHA among women have been found in our study and previous studies have 
reported higher DHA concentrations in women compared to men independently by intake
54,129
. DHA may 
have sex-specific effects on the development of CVD, (e.g., platelet aggregation have ben shown to be 
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inhibited by DHA supplementation in women compared to men)
130,131
. Our findings of protection of 
serum EPA and DHA and all-cause mortality in both men and women is in line with what reported in 
previous studies 
132
.  
 
 
The moderate increased of CVD incidence in women in relation to high serum concentration of ALA is 
difficult to interpret. In a randomized trial- Lyon Diet Heart Study- the authors have suggested protective 
effects of ALA intake when consumed as margarines on CVD 
133
. However, epidemiological evidence of 
CHD-protective effects of circulating ALA is somewhat inconclusive
134,135
 
136
. Some studies reported no 
clear association where others have reported cardioprotective effects of ALA
134
.  Moreover, no clear 
assocciation between serum ALA and intake of vegetable oils and margarine (major dietary source of 
ALA) were observed in the Project I. As previously suggested, circulating ALA concentration is affected 
by factors not related to ALA intake and a high proportion of circulating ALA may be an indicator of 
poor conversion of ALA to longer chained n-3 PUFA
135
. In our study, ALA was only associated with an 
increased CVD risk among women with the lower EPA and DHA concentrations (data not shown). In 
addition, the mean ALA concentrations in women (0.90 %) and men (0.87%) in the present study were 
above previously reported mean or median serum CE ALA concentrations in free-living individuals 
(0.40-0.84%) 
90,136-138
.  
In line with our results of seum EPA and DHA and total mortality, a recent investigation in elderly 
American men and women reported that plasma phospholipid long-chain n-3 PUFA were inversely 
associated with total mortality
106
.  
Our results of a protection of serum LA and total mortality are consistent with previous other studies 
where plasma phospholipid LA was inversely associated and total and CVD mortality among middle-
aged/older men in Northern Europe
136,139
. Such data are well in line with the robust LDL-cholesterol 
lowering effects when compared with saturated fats, and is a likely contributing mechanism behind the 
inverse associations between LA and CHD and CVD mortality observed in several cohorts 
90,136,140
. 
Strengths  
 
Strength of the present thesis is the fact that it is based on a large, representative, and thoroughly 
characterized sample of 60-year-old men and women residing in Stockholm County, Sweden.  
The study’s age homogeneity means we may exclude bias related to age. 
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The studies included in this thesis is one of the largest globally to relate self-reported fat intake to fatty 
acids in serum cholesterol esters (Project I), and to relate serum PUFA-reflecting the corresponding 
dietary intake-to incidence of CVD and all-causes mortality(Project III).  
Another strength is related to our use of quantile regression modelling of associations that may be give a 
more detailed picture of the distribution of the fatty acids. As it may identify in our results, the association 
may vary across percentiles of the fatty acid distribution (Project I) 
Long follow up (14.5y) and the use of Swedish register for the determination of incident of CVD and all-
causes mortality might reduce possible non differential misclassification of the outcome
141
. (Project II-III) 
Limitations 
A potential limitation of our study is the fact that the information about diet was gathered using a self-
reported questionnaire that included relatively crude questions about dietary intake. We could not fully 
assess the exact fat intake from our dietary questionnaires as the questions do not specify the serving size 
and allow no detailed calculation of nutrients and energy intake. For this reason, some observed 
associations between diet scores and specific serum cholesterol fatty acids may be diluted, assuming that 
intakes of different dietary items are equally underreported and overreported
142-145
. In addition, results 
based on questionnaires composed of simple questions such as ours, as opposed to more detailed 
nutritional information that food frequency questionnaires offer, require less exact recall and are easier to 
fill out accurately, perhaps making it more subject to smaller measurement error (Project I-II).  Another 
study limitation was that serum cholesterol fatty acids were expressed as percentages of the total amount 
and not as absolute values. An increase in the proportion may not be relevant as the corresponding 
absolute increase. Furthermore, fatty acid proportions are inherently an imperfect reflection of dietary 
intake fat because to some extent the amount depends on endogenous synthesized SFA and MUFA. 
Moreover, the chosen method of measurement does not include measurements of trans fatty acids. The 
long-term storage of our sample before analysis may also be a weakness of the present study, although the 
samples were not previously defrosted and it has been shown that storage for 12 years at -80°C does not 
change the composition of the polyunsaturated fatty acids
146,147
 (Project I, III).  
Dietary intake and serum fatty acids were measured only at baseline (14.5 years earlier) without repeated 
measurements (Paper I-III). Thus, dietary habits and consequently serum fatty acids might be changed 
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over the follow-up period and affect the true estimates. However, we might speculate that elderly people 
are less prone to change their habits and in particular dietary habits (Paper II). Although we adjusted for 
several possible confounding and intermediate factors, we can not exclude possible residual confounding 
from other possible factors (Project I-III). We might not exclude competitive risk from other disease 
(Project II-III). 
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CONCLUSIONS 
 
In this PhD thesis the associations between diet and in specific dietary fats and CVD (and all-causes 
mortality) have been investigated. The results from this large Swedish cohort of 60 years old men and 
women suggested that: 
 
- independently from sex, physical activity, and smoking status, fats from fish intake strongly associate 
with serum cholesterol fatty acids EPA and DHA, whereas intake of margarines and vegetable oils 
associate with PUFA. The intake of fats from foods containing saturated fat in general, specifically dairy 
products, associates only slightly with myristic acid, pentadecanoic acid, and stearic acids, and intake of 
processed meat, visible fat and eggs does not show any relation with serum cholesterol fatty acids.  
 
- independently from physical activity, smoking status and education, the association between self-
reported dietary intake and incidence of CVD and all-causes of mortality is sex- and food specific. In 
women excess intake of spread butter or margarine and oily potatoes may have more negative effects on 
incidence of CVD where in men high intake of butter, eggs are harmful whereas intake of fruits is 
protective for all-causes mortality. In general, no association between fats from dairy, meat, fish product 
and vegetable oils and margarine and CVD and all-causes mortality have been shown in both men and 
women.  
 
- associations between specific serum PUFA and incidence of CVD are to some extent sex-specific. 
Serum EPA, DHA are protective for CVD incidence in women only and for all-causes mortality in both 
sex. ALA has a negative effect on CVD incidence in women where LA is protective for all-causes 
mortality in men. 
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APPENDIX 
Table 1: Age Standardized death rates from CHD, adults aged under 65, by sex,1980 to 2010,Europe (deaths per 
100,000)
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Table 2: Age Standardized death rates from stroke, adults aged under 65, by sex,1980 to 2010,Europe (deaths per 
100,000) 
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Table 3: Dietary questionnaire used in the cohort of 60-year-old men and women. 
 
1) How many sandwiches do you eat per day? a 
 
None  
1-2 
 3-5  
at least 6  
2) What do you use as “butter”? 
Nothing 
Butter/Bregott  
margarine/ low-fat margarine  
Nytta (Becel) 
3) How much “butter” do you usually spread per slice of bread? 
 
Nothing 
Less than ½ serving 
½ serving (5g) 
At least 1 serving (10g) 
4) How much cheese do you use per slice if you put cheese on your slice? 
I never put cheese on my bread 
1 slice or less 
2 slices 
3 slices or more  
5) What sort of milk or yoghurt do you prefer? 
I avoid lowfat products 
Low-fat products or nothing 
I do not care 
Standard (3% fat) 
6) How often do you eat fruit and/or berries? a 
Seldom 
A couple of times per week  
Daily 
Several times per day 
7) How often do you eat vegetables or roots/tubers? a  
Never 
<1 time per day 
Almost daily or daily 
>1 time per day 
8) How often do you eat lean fish (cod, flounder)?  
Seldom/never 
1-2 times per week 
≥3 times per week 
9) How often do you eat fatty fish (salmon, herring, mackerel)?  
Seldom/neve 
1-2 times per week  
≥3 times per week 
10) How often do you eat bacon or sausages as a main dish? 
Never/almost never 
2 times per month 
Once per week 
1-2 times per week  
11) Do you cut off visible fat before you eat your meat? 
Yes 
Sometimes 
No 
12) How often do you eat pan-fried potatoes, French fries, or potato au gratin? a 
Almost never 
A couple times per month 
  1 time per week 
2 times per week 
13) How many eggs do you eat? 
≤1 time per week 
4-5 times per week 
2-3 times per week 
≥1 per day 
14) What kind of fat/oil do you use to panfry? 
 
I do not eat pan fried foods 
Liquid margarine or oil 
Butter or Bregott 
Margarine 
15) How often do you use cream, or sour cream (“crème fraiche”, sauces)? 
 Seldom =0 
≥2 times per month=0 
Once a week=1 
≥2 times per week=2 
16) How often do you eat potato chips, chocolate, croissants, Danish pastries, cakes, or cheeses? 
a  
Almost  never =0 
≥ 2 times per month=0 
Once a week=1 
≥2 times per week =2 
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Table 4: Score points according to questionnaire answers in the cohort of 60-year-old men and women. 
 
 
1) What do you use as “butter”? 
Set of points contributing to Dairyscore and Satscore: 
Nothing=0 
Margarine/ low-fat margarine=1  
Nytta (Becel)=1  
Butter/Bregott =2 
Set of points contributing to Vegoilscore: 
Nothing=0 
Butter/Bregott=0  
Margarine/ low-fat margarine=1  
Nytta (Becel)=2 
2) How much “butter” do you usually spread per slice of bread? 
 
Set of points contributing to Dairyscore and Satscore: 
Nothing=0 
Less than ½ serving=0  
½ serving (5g)=1 
At least 1 serving (10g)=2 
3) How much cheese do you use per slice if you put cheese on your 
slice? 
Set of points contributing to Dairyscore and Satscore: 
Nothing=0 
1 slice or less=0 
2 slices=1 
3 slices or more=2 
4) What sort of milk or yoghurt do you prefer? 
Set of points contributing to Dairyscore and Satscore: 
Nothing=0 
Low-fat products or nothing=0 
I do not care=1  
Standard (3% fat)=2 
5) How often do you eat lean fish (cod, flounder)? 
Set of points contributing to Fishscore: 
Seldom/never=0 
1-2 times per week=1  
≥3 times per week =2 
6) How often do you eat fatty fish (salmon, herring, mackerel)?  
Set of points contributing to Fishscore: 
Seldom/never=0 
1-2 times per week=1  
≥3 times per week =2 
7) How often do you eat bacon, or sausages as a main dish? 
Set of points contributing to Meatscore: 
Never/almost never=0 
2 times per month=0  
Once per week=1 
1-2 times per week=2  
8) Do you cut off visible fat before you eat your meat? 
Set of points contributing to Meatscore: 
Yes=0 
Sometimes=1 
No=2 
9) How many eggs do you eat? 
Set of points contributing to Meatscore: 
≤1 time per week=0 
4-5 times per week=1 
2-3 times per week=1 
≥1 per day=2 
10) What kind of fat/oil do you use to panfry? 
 
Set of points contributing to Dairyscore and Satscore: 
I do not eat pan fried food =0 
Liquid margarine or oil=1 
Butter or Bregott=2  
Margarine=2 
Set of points contributing to Vegoilscore: 
I do not eat pan fried foods=0 
Butter or Bregott=0  
Margarine=1  
Liquid margarine or oil=2 
11) How often do you use cream, or sour cream (“crème fraiche”, 
sauces)? 
Set of points contributing to Dairyscore and Satscore: 
 Seldom=0 
≥2 times per month=0 
Once a week=1 
≥2 times per week=2 
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Table 5: Distribution of diet score points (25th, 50th, 75 th) in 2,132 women (W) and 1,975 men (M) included in the 
cohort of 60-year-old men and women. 
 
 
Sex 25th 50th 75th 
 
W 0 1 1 
Fishscore M 0 1 1 
 
W 1 2 2 
Vegoilscore M 1 2 2 
 
W 4 5 7 
Dairyscore M 4 6 7 
 
W 5 6 8 
Satscore M 5 8 10 
 
W 0 1 2 
Meatscore M 1 2 3 
 
 
 
 
Table 6 : Percentiles (10th, 25th, 50th, 75th, and 90th) of serum cholesterol ester fatty acid distribution, expressed as percentage of the 
total amount, in 2,017 women (W) and 2,133 men (M) included in the cohort of 60-year-old men and women. 
  Percentile value of fatty acids (%)  
 
Sex 10th 25th 50th 75th 90th P value
a 
 
W 0∙646 0∙751 0∙885 1∙013 1∙134  
14 : 0 M 0∙661 0∙763 0∙895 1∙034 1∙186 <0∙01 
 
W 0∙166 0∙187 0∙212 0∙242 0∙272  
15 : 0 M 0∙168 0∙193 0∙221 0∙252 0∙284 <0∙001 
 
W 10∙397 10∙777 11∙189 11∙635 12∙108  
16 : 0 M 10∙709 11∙099 11∙565 12∙035 12∙492 <0∙001 
 
W 0∙609 0∙669 0∙744 0∙833 0∙944  
18 : 0 M 0∙641 0∙704 0∙784 0∙876 0∙981 <0∙001 
 
W 2∙484 2∙955 3∙606 4∙521 5∙645  
16 : 1n-7 M 2∙103 2∙509 3∙156 4∙134 5∙408 <0∙001 
 
W 20∙527 21∙522 22∙607 23∙785 24∙995  
18 : 1n-9 M 20∙515 21∙559 22∙581 23∙805 25∙144 0∙60 
 
W 43∙081 45∙879 48∙663 51∙187 53∙546  
18 : 2n-6 M 42∙946 45∙891 48∙863 51∙244 53∙388 0∙60 
 
W 0∙527 0∙685 0∙884 1∙116 1∙369  
18 : 3n-6 M 0∙527 0∙664 0∙841 1∙059 1∙304 <0∙001 
 
W 0∙546 0∙624 0∙716 0∙825 0∙926  
20 : 3n-6 M 0∙550 0∙621 0∙708 0∙810 0∙922 0∙11 
 
W 4∙939 5∙520 6∙219 7∙041 7∙835  
20 : 4n-6 M 4∙930 5∙528 6∙265 6∙986 7∙805 0∙70 
 
W 0∙659 0∙759 0∙874 1∙015 1∙145  
18 : 3n-3 M 0∙627 0∙738 0∙850 0∙978 1∙112 <0∙001 
 W 1∙168 1∙465 1∙880 2∙467 3∙226  
20 : 3n-6 M 1∙086 1∙416 1∙856 2∙440 3∙272 0∙11 
 
W 0∙646 0∙758 0∙897 1∙062 1∙236  
22 : 6n-3 M 0∙601 0∙728 0∙877 1∙050 1∙234 <0∙01 
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W 12∙045 12∙558 13∙046 13∙614 14∙207  
Tot. SFA M 12∙448 12∙918 13∙460 14∙070 14∙666 <0∙001 
 
W 23∙336 24∙661 26∙331 28∙138 30∙178  
Tot. MUFA M 22∙962 24∙346 25∙827 27∙739 30∙141 <0∙001 
 
W 56∙047 58∙407 60∙591 62∙508 64∙137  
Tot. PUFA M 55∙883 58∙293 60∙624 62∙464 64∙072 0∙61 
 
W 0∙226 0∙267 0∙321 0∙398 0∙487  
16 : 1n-7/16 : 0 M 0∙187 0∙220 0∙272 0∙354 0∙451 <0∙001 
 
 
aDifferences across sex were tested using the Wilcoxon’s rank sum test (Mann-Whitney’s test), at the 50th percentile only.  P-values 
< 0∙05 were considered significant.    
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Table 7 (ae): Percentile differences with 95% confidence intervals, expressed as serum fatty acid proportions, at the 10th, 25th, 50th, 75th and 90th percentile of serum fatty acids 
distribution, across points of increase of diet scores (Fishscore, Vegoilscore, Dairyscore, Satscore, Meatscore). Sex specific results based on 4,030 participants of the cohort of 60-year-
old men and women. 
 
  Percentile differences of fatty acids (%) 
Fatty Acid  10th 25th 50th 75th 90th 
 
(a) Fishscore 
20 : 5n-3 (EPA) 
Crude W 21∙99 (17∙91, 26∙07) 24∙91 (21∙41, 28∙41) 29∙98 (25∙08, 34∙88) 41∙63 (34∙05, 49∙21) 56∙77 (40∙38, 73∙16) 
Crude M 23∙01 (18∙89, 27∙13) 30∙99 (25∙94, 36∙03) 37∙32 (31∙99, 42∙65) 50∙64 (42∙78, 58∙50) 60∙98 (47∙03, 74∙94) 
Adjusteda W 22∙81 (18∙47, 27∙16) 24∙96 (21∙17, 28∙74) 28∙82 (23∙86, 33∙78) 38∙36 (30∙33, 46∙40) 54∙09 (38∙04, 70∙14) 
 Adjusteda M 20∙25 (15∙62, 24∙87) 29∙88 (24∙96, 34∙80) 35∙76 (30∙24, 41∙29) 48∙51 (40∙16, 56∙86) 55∙22 (41∙67, 68∙76) 
22 : 6n-3 (DHA) 
Crude W 9∙63 (8∙14, 11∙11) 9∙73 (8∙30, 11∙17) 10∙30 (8∙78, 11∙83) 11∙43 (9∙55, 13∙30) 13∙94 (11∙29, 16∙58) 
Crude M 9∙05 (7∙12, 10∙99) 12∙10 (10∙61, 13∙60) 12∙76 (11∙17, 14∙35) 13∙83 (11∙66, 16) 14∙14 (11∙21, 17∙06) 
Adjusteda W 9∙35 (7∙66, 11∙03) 9∙22 (7∙77, 10∙67) 10∙09 (8∙52, 11∙66) 10∙62 (8∙64, 12∙61) 14∙05 (11∙27, 16∙84) 
 Adjusteda M 8∙85 (6∙83, 10∙86) 12∙01 (10∙35, 13∙67) 12∙19 (10∙52, 13∙85) 12∙72 (10∙76, 14∙69) 14∙96 (11∙72, 18∙20) 
 
(b) Vegoilscore 
 
Crude W 67∙03 (29∙70, 104∙36) 42∙15 (16∙52, 67∙77) 30∙54 (7∙94, 53∙15) 29∙01 (4∙80, 53∙22) 10∙98 (17∙22, 39∙19) 
18 : 2n-6 Crude M 81∙38 (37∙78, 124∙98) 46∙11 (19∙35, 72∙88) 49∙90 (27∙38, 72∙41) 27∙22 (5∙75, 48∙68) 34∙33 (5∙17, 63∙50) 
 Adjusteda W 56∙72 (18∙80, 94∙65) 49∙51 (25∙12, 73∙89) 26∙46 (5∙65, 47∙26) 19∙11 (4∙39, 42∙61) 1∙32 (22∙10, 24∙74) 
 Adjusteda M 73∙47 (32∙11, 114∙82) 36∙91 (7∙80, 66∙01) 34∙17 (11∙78, 56∙55) 27∙19 (6∙37, 48∙01) 22∙16 (1∙60, 45∙93) 
 
Crude W 0∙66 (0∙79, 2∙10) 0∙25 (0∙88, 1∙38) 0∙08 (1∙01, 1∙17) 0∙37 (1∙02, 1∙77) 0∙86 (1∙11, 2∙83) 
18 : 3n-3 Crude M 0∙91 (2∙46, 0∙65) 0∙97 (2∙09, 0∙16) 0∙55 (1∙63, 0∙52) 0∙72(1∙99, 0∙55) 0∙11 (1∙92, 1∙70) 
 Adjusteda W 0∙09 (1∙29, 1∙48) 0∙05 (1∙03, 1∙12) 0∙04 (1∙06, 1∙15) 0∙22 (1∙16, 1∙59) 0∙71 (1∙35, 2∙78) 
 Adjusteda M 0∙81 (2∙29, 0∙68) 0∙97 (2∙10, 0∙15) 0∙61 (1∙66, 0∙43) 0∙68 (1∙97, 0∙62) 0∙02 (1∙74, 1∙79) 
 Crude W 6∙55 (12∙62, 0∙47) 8∙08 (12∙58, 3∙58) 7∙71 (12∙12, 3∙30) 11∙02 (16∙28, 5∙75) 11∙48 (19∙89, 3∙07) 
Tot. SFA Crude M 6∙99 (11∙89, 2∙08) 9∙98 (15∙27, 4∙68) 10∙40 (15∙58, 5∙22) 11∙36 (17∙57, 5∙14) 15∙94 (23∙91, 7∙96) 
 Adjusteda W 7∙98 (14∙23, 1∙73) 6∙97 (11∙32, 2∙59) 7∙88 (12∙31, 3∙46) 11∙78 (16∙86, 6∙71) 11∙34 (20∙10, 2∙58) 
 Adjusteda M 6∙79 (12∙09, 1∙49) 9∙51 (14∙85, 4∙17) 10∙31 (15∙60, 5∙02) 12∙63 (18∙79, 6∙47) 14∙87 (22∙62, 7∙12) 
 Crude W 62∙13 (30∙26, 94∙00) 38∙91 (15∙91, 61∙93) 31∙14 (14∙64, 47∙64) 25∙37 (9∙47, 41∙27) 21∙47 (0∙09, 42∙84) 
Tot. PUFA Crude M 75∙25 (37∙08, 113∙43) 66∙89 (42∙57, 91∙22) 35∙19 (19∙00, 51∙38) 39∙14 (21∙10, 57∙18) 30∙49 (10∙14, 50∙83) 
 Adjusteda W 62∙39 (29∙25, 95∙53) 41∙36 (22∙77, 59∙96) 33∙52 (16∙17, 50∙86) 17∙60 (1∙13, 24∙06) 21∙01 (0∙77, 41∙26) 
 Adjusteda M 56∙89 (13∙32, 100∙45) 65∙13 (42∙31, 87∙94) 32∙42 (14∙97, 49∙89) 24∙54 (8∙45, 40∙63) 23∙11 (1∙33, 44∙89) 
 
(c) Dairyscore 
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14 : 0 
Crude W 1∙65 (1∙14, 2∙15) 1∙34 (0∙79, 1∙89) 0∙96 (0∙47, 1∙46) 1∙27 (0∙75, 1∙80) 1∙04 (0∙18, 1∙90) 
Crude M 1∙33 (0∙7, 1∙94) 1∙37 (0∙88, 0∙19) 1∙09 (0∙60, 1∙59) 0∙77 (0∙22, 1∙33) 1∙20 (0∙37, 2∙01) 
Adjusteda W 1∙62 (1∙07, 2∙16) 1∙35 (0∙79, 1∙91) 1∙11 (0∙60, 1∙63) 1∙42 (0∙90, 1∙94) 1∙39 (0∙46, 2∙32) 
 Adjusteda M 1∙17 (0∙57, 1∙77) 1∙25 (0∙77, 1∙73) 1∙10 (0∙58, 1∙63) 0∙81 (0∙21, 1∙42) 1∙26 (0∙42, 2∙10) 
15 : 0 
 
Crude W 0∙27 (0∙15, 0∙39) 0∙31 (0∙21, 0∙40) 0∙28 (0∙18, 0∙39) 0∙32 (0∙18, 0∙45) 0∙27 (0∙05, 0∙48) 
Crude M 0∙26 (0∙13, 0∙40) 0∙28 (0∙18, 0∙39) 0∙20 (0∙10, 0∙30) 0∙27 (0∙13, 0∙41) 0∙36 (0∙17, 0∙55) 
Adjusteda W 0∙26 (0∙11, 0∙41) 0∙31 (0∙21, 0∙41) 0∙35 (0∙24, 0∙45) 0∙33 (0∙20, 0∙45) 0∙37 (0∙15, 0∙59) 
 Adjusteda M 0∙35 (0∙23, 0∙47) 0∙33 (0∙23, 0∙43) 0∙24 (013, 036) 0∙35 (0∙22, 0∙49) 0∙43 (0∙23, 0∙62) 
16 : 0 
 
Crude W 1∙18 (3∙44, 1∙08) 3∙75 (5∙62, 1∙88) 3∙39 (4∙85, 1∙92) 4∙72 (6∙92, 2∙51) 5∙51 (8∙47, 2∙55) 
Crude M 0∙53 (2∙49, 1∙44) 1∙83 (3∙51, 0∙16) 1∙69 (3∙41,  0∙03) 2∙50 (4∙61, 0∙38) 2∙99 (5∙47, 0∙51) 
Adjusteda W 1∙70 (3∙95, 0∙55) 3∙80 (5∙67, 1∙94) 3∙32 (4∙79, 1∙86) 4∙13 (6∙36, 1∙90) 5∙19 (7∙93, 2∙45) 
 AdjustedaM 0∙92 (2∙75, 0∙90) 2∙09 (3∙89, 0∙30) 2∙85 (4∙62, 1∙08) 2∙75 (4∙80, 0∙70) 3∙71 (6∙09, 1∙33) 
18 : 0 
 
Crude W 0∙41 (0∙10, 0∙71) 0∙34 (0∙04, 0∙64) 0∙51 (0∙22, 0∙79) 0∙46 (0∙01, 0∙94) 0∙57 (0∙13, 1∙28) 
Crude M 0∙50 (0∙12, 0∙89) 0∙45 (0∙17, 0∙73) 0∙28 (0∙02, 0∙58) 0∙33 (0∙06, 0∙71) 0∙70 (0∙03, 1∙37) 
Adjusteda W 0∙43 (0∙08, 0∙78) 0∙34 (0∙03, 0∙65) 0∙38 (0∙08, 0∙68) 0∙45 (0∙02, 0∙92) 0∙33 (0∙39, 1∙05) 
 Adjusteda M 0∙64 (0∙27, 1∙00) 0∙47 (0∙19, 0∙75) 0∙26 (0∙06, 0∙59) 0∙24 (017, 0∙64) 0∙64 (0∙09, 1∙37) 
16 : 1n-7/16 : 0 
Crude W 0∙02 (0∙17, 0∙21) 0∙11 (0∙33, 0∙10) 0∙40 (0∙65, 0∙14) 0∙27 (0∙62, 0∙08) 0∙11 (0∙65, 0∙42) 
Crude M 0∙05 (0∙13, 0∙22) 0∙19 (0∙01, 0∙39) 0∙17 (0∙05, 0∙39) 0∙37 (0∙02, 0∙75) 0∙26 (0∙92, 0∙41) 
Adjusteda W 0∙02 (0∙20, 0∙23) 0∙12 (0∙36, 0∙12) 0∙61 (0∙88, 0∙35) 0∙36 (0∙67, 0∙04) 0∙34 (0∙98, 0∙30) 
 Adjusteda M 0∙00 (0∙17, 0∙17) 0∙08 (0∙10, 0∙26) 0∙10 (0∙12, 0∙33) 0∙10 (0∙28, 0∙48) 0∙15 (0∙73, 0∙43) 
Tot. SFA 
Crude W 0∙54 (2∙52, 3∙60) 1∙05 (3∙33, 1∙24) 2∙20 (4∙10, 0∙30) 2∙11 (4∙77, 0∙55) 4∙71 (8∙18, 1∙24) 
Crude M 1∙40 (0∙76, 3∙56) 0∙59 (1∙89, 3∙07) 0∙33 (2∙65, 1∙98) 1∙08 (3∙84, 1∙69) 0∙32 (4∙48, 3∙84) 
Adjusteda W 0∙32 (2∙62, 3∙25) 1∙98 (4∙05, 0∙08) 1∙96 (3∙89, 0∙02) 2∙15 (4∙81, 0∙51) 4∙53 (7∙99, 1∙06) 
 Adjusteda M 0∙84 (1∙47, 3∙15) 0∙76 (1∙74, 3∙25) 0∙44 (2∙73, 1∙86) 1∙58 (4∙33, 1∙18) 0∙87 (3∙43, 5∙18) 
 Crude W 0∙19 (2∙17, 1∙79) 2∙16 (4∙78, 0∙46) 5∙60 (8∙62, 2∙58) 4∙51 (8∙86, 0∙17) 6∙09 (12∙71, 0∙52) 
 Crude M 1∙39 (0∙46, 3∙23) 1∙55 (0∙58, 3∙68) 0∙75 (2∙05, 3∙55) 2∙98 (1∙43, 7∙28) 4∙80 (13∙45, 3∙85) 
16 : 1n-7 Adjusteda W 0∙75 (3∙03, 1∙53) 3∙11 (5∙76, 0∙46) 7∙52 (10∙43, 4∙61) 7∙22 (11∙43, 3∙01) 4∙65 (12∙06, 2∙76) 
 Adjusteda M 0∙72 (1∙22, 2∙65) 0∙00 (2∙21, 2∙21) 0∙15 (3∙10, 2∙79) 0∙36 (4∙20, 4∙93) 1∙78 (9∙86, 6∙31) 
 Crude W 9∙15 (3∙59, 14∙71) 4∙25 (0∙57, 9∙07) 2∙40 (0∙20, 6∙79) 3∙03 (2∙24, 8∙30) 0∙17 (7∙83, 8∙16) 
 Crude M 0∙83 (6∙12, 7∙79) 4∙80 (0∙88, 8∙72) 3∙84 (0∙60, 8∙29) 9∙80 (4∙44, 15∙16) 10∙07 (1∙53, 18∙60) 
18 : 1n-9 Adjusteda W 6∙85 (0∙90, 12∙81) 2∙63 (∙2∙40, 7∙67) 2∙04 (2∙09, 6∙17) 1∙29 (6∙44, 3∙85) 2∙37 (9∙48, 4∙74) 
 Adjusteda M 1∙06 (5∙60, 7∙71) 5∙30 (1∙26, 9∙35) 5∙95 (1∙28, 10∙62) 5∙99 (0∙41, 11∙58) 6∙02 (2∙48, 14∙53) 
 
(d) Satscore 
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14 : 0 
Crude W 0∙71 (0∙21, 1∙22) 0∙46 (0∙02, 0∙89) 0∙15 (0∙23, 0∙53) 0∙64 (0∙21, 1∙07) 0∙36 (0∙36, 1∙08) 
Crude M 0∙74 (0∙33, 1∙15) 0∙69 (0∙33, 1∙06) 0∙49 (0∙12, 0∙86) 0∙13 (0∙32, 0∙58) 0∙52 (0∙08, 1∙13) 
Adjusteda W 0∙51 (0∙10, 0∙92) 0∙41 (0∙02, 0∙85) 0∙14 (0∙25, 0∙52) 0∙57 (0∙14, 1∙01) 0∙68 (0∙03, 1∙39) 
 Adjusteda M 0∙65 (0∙20, 1∙10) 0∙63 (0∙27, 0∙99) 0∙46 (0∙07, 0∙84) 0∙20 (0∙26, 0∙65) 0∙50 (0∙14, 1∙15) 
15 : 0 
Crude W 0∙08 (0∙02, 0∙17) 0∙10 (0∙02, 0∙18) 0∙13 (0∙05, 0∙27) 0∙13 (0∙04, 0∙30) 0∙08 (0∙04, 0∙20) 
Crude M 0∙12 (0∙02, 0∙02) 0∙13 (0∙05, 0∙22) 0∙06 (0∙01, 0∙14) 0∙12 (0∙02, 0∙02) 0∙05 (0∙14, 1∙15) 
Adjusteda W 0∙08 (0∙04, 0∙20) 0∙14 (0∙07, 0∙22) 0∙16 (0∙07, 0∙25) 0∙19 (0∙09, 0∙29) 0∙18 (0∙01, 0∙35) 
 Adjusteda M 0∙12 (0∙02, 0∙21) 0∙13 (0∙05, 0∙22) 0∙06 (0∙01, 0∙14) 0∙12 (0∙02, 0∙22) 0∙16 (0∙02, 0∙31) 
 
Crude W 0∙53 (2∙35, 1∙29) 2∙48 (4∙00, 0∙96) 2∙57 (3∙74, 1∙40) 4∙19 (5∙89, 2∙50) 4∙54 (6∙83, 2∙24) 
16 : 0 Crude M 0∙06 (1∙51, 1∙40) 1∙50 (2∙84, 0∙16) 1∙33 (2∙66, 0∙01) 1∙87 (3∙50, 0∙24) 2∙17 (3∙86, 0∙48) 
 Adjusteda W 0∙72 (2∙50, 1∙07) 2∙56 (4∙13, 1∙00) 2∙50 (3∙68, 1∙32) 3∙88 (5∙66, 1∙32) 4∙71 (7∙06, 2∙37) 
 Adjusteda M 0∙66 (2∙05, 0∙73) 2∙04 (3∙33, 0∙74) 1∙99 (3∙36, 0∙62) 2∙26 (3∙85, 0∙67) 2∙51 (4∙31, 0∙71) 
 
Crude W 0∙29 (0∙04, 0∙55) 0∙31 (0∙09, 0∙54) 0∙38 (0∙16, 0∙61) 0∙44 (0∙06, 0∙81) 0∙31 (0∙27, 0∙90) 
18 : 0 Crude M 0∙39 (0∙12, 0∙65) 0∙32 (0∙11, ∙53) 0∙21 (0∙03, 0∙45) 0∙30 (0∙02, 0∙59) 0∙69 (0∙19, 1∙19) 
 Adjusteda W 0∙32 (0∙05, 0∙59) 0∙34 (0∙11, 0∙57) 0∙32 (0∙08, 0∙57) 0∙42 (0∙06, 0∙78) 0∙21 (0∙35, 0∙76) 
 Adjusteda M 0∙36 (0∙11, 0∙60) 0∙31 (0∙10, 0∙53) 0∙20 (0∙04, 0∙45) 0∙28 (0∙01, 0∙58) 0∙64 (0∙09, 1∙19) 
 
Crude W 0∙04 (0∙20, 0∙12) 0∙17 (0∙34, 0∙00) 0∙41 (0∙60, 0∙22) 0∙34 (0∙63, 0∙06) 0∙22 (0∙66, 0∙21) 
16 : 1n-7/16 : 0 Crude M 0∙04 (0∙09, 0∙18) 0∙16 (0∙00, 0∙32) 0∙32 (0∙03, 0∙60) 0∙32 (0∙03, 0∙60) 0∙12 (0∙64, 0∙40) 
 Adjusteda W 0∙02 (0∙19, 0∙15) 0∙23 (0∙42, 0∙04) 0∙60 (0∙81, 0∙39) 0∙41 (0∙68, 0∙14) 0∙34 (0∙83, 0∙15) 
 Adjusteda M 0∙03 (0∙16, 0∙10) 0∙08 (0∙06, 0∙22) 0∙09 (0∙07, 0∙26) 0∙15 (0∙14, 0∙44) 0∙00 (0∙42, 0∙42) 
 
Crude W 0∙65 (1∙73, 3∙04) 0∙74 (2∙55, 1∙08) 1∙99 (3∙53, 0∙46) 3∙24 (5∙42, 1∙06) 4∙91 (7∙65, 2∙18) 
Tot. SFA Crude M 0∙57 (1∙02, 2∙15) 0∙22 (2∙11, 1∙67) 0∙57 (2∙33, 1∙19) 1∙19 (3∙23, 0∙84) 0∙77 (4∙04, 2∙48) 
 Adjusteda W 0∙14 (2∙11, 2∙38) 1∙63 (3∙23, 0∙02) 1∙68 (3∙22, 0∙14) 2∙52 (4∙70, 0∙34) 4∙78 (7∙51, 2∙04) 
 Adjusteda M 0∙36 (1∙33, 2∙06) 0∙48 (2∙33, 1∙37) 0∙78 (2∙52, 0∙97) 1∙49 (3∙59, 0∙61) 0∙81 (4∙00, 2∙37) 
 Crude W 0∙62 (2∙19, 0∙93) 2∙92 (4∙98, 0∙87) 5∙53 (7∙92, 3∙14) 4∙41 (8∙06, 0∙76) 5∙36 (10∙36, 0∙35) 
 Crude M 1∙26 (0∙15, 2∙68) 1∙44 (0∙17, 3∙06) 1∙05 (1∙03, 3∙13) 2∙46 (0∙91, 5∙84) 1∙45 (8∙31, 5∙40) 
16 : 1n-7 Adjusteda W 1∙32 (3∙00, 0∙35) 3∙92 (6∙04, 1∙81) 6∙48 (8∙80, 4∙17) 6∙90 (10∙28, 3∙53) 4∙66 (10∙08, 0∙77) 
 Adjusteda M 0∙50 (0∙94, 1∙95) 0∙000 (1∙66, 1∙66) 0∙11 (2∙34, 2∙11) 0∙85 (2∙57, 4∙27) 0∙69 (6∙77, 5∙38) 
 Crude W 5∙90 (1∙53, 10∙27) 0∙99 (2∙88, 4∙85) 1∙08 (2∙47, 4∙64) 1∙74 (2∙37, 5∙85) 0∙67 (6∙83, 5∙47) 
 Crude M 2∙83 (2∙07, 7∙73) 4∙82 (1∙94, 7∙69) 8∙85 (4∙99, 1∙27) 7∙90 (1∙46, 14∙33) 7∙89 (1∙46, 14∙33) 
18 : 1n-9 Adjusteda W 4∙88 (0∙56, 9∙20) 1∙92 (2∙12, 5∙96) 0∙15 (3∙43, 3∙14) 2∙24 (6∙24, 1∙75) 1∙94 (7∙87, 3∙99) 
 Adjusteda M 1∙32 (3∙60, 6∙24) 4∙20 (0∙99, 7∙40) 5∙53 (1∙92, 9∙13) 5∙64 (1∙59, 9∙69) 4∙39 (1∙98, 10∙76) 
 Crude W 2∙22 (3∙20, 7∙65) 2∙69 (7∙77, 2∙39) 2∙49 (7∙72, 2∙39) 2∙49 (7∙71, 2∙74) 5∙90 (17∙53, 5∙72) 
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 Crude M 0∙43 (5∙91, 5∙04) 7∙29 (3∙10, 11∙48) 6∙54 (1∙91, 11∙16) 11∙64 (5∙11, 18∙18) 9∙11 (3∙24, 21∙46) 
Tot. MUFA Adjusteda W 0∙40 (5∙61, 6∙42) 1∙98 (7∙81, 3∙84) 9∙00 (14∙60, 3∙41) 8∙67 (15∙48, 1∙85) 8∙84 (19∙22, 1∙55) 
 Adjusteda M 1∙46 (7∙23, 4∙31) 5∙65 (1∙29, 10∙00) 2∙24 (2∙27, 6∙75) 7∙57 (1∙07, 14∙08) 5∙96 (4∙37, 16∙39) 
 
(e) Meatscore 
 
Crude W 1∙59 (2∙71, 0∙48) 1∙96 (2∙89, 1∙03) 2∙03 (2∙89, 1∙18) 1∙80 (2∙80, 0∙79) 1∙30 (2∙87, 0∙27) 
14 : 0 Crude M 0∙34 (1∙29, 0∙61) 0∙47 (1∙26, 0∙32) 1∙04 (1∙87, 0∙20) 1∙30 (2∙16, 0∙44) 1∙30 (2∙42, 0∙53) 
 Adjusteda W 1∙19 (2∙25, 0∙13) 1∙85 (2∙89, 0∙82) 2∙25 (3∙12, 1∙38) 1∙64 (2∙69, 0∙58) 1∙37 (2∙93, 0∙20) 
 Adjusteda M 0∙62 (1∙58, 0∙33) 0∙65 (1∙52, 0∙22) 0∙90 (1∙72, 0∙08) 1∙28 (2∙19, 0∙36) 1∙15 (2∙54, 0∙24) 
 
Crude W 0∙24 (0∙46, 0∙03) 0∙34 (0∙51, 0∙18) 0∙30 (0∙49, 0∙11) 0∙26 (0∙53, 0∙01) 0∙27 (0∙65, 0∙10) 
15 : 0 Crude M 0∙20 (0∙41, 0∙00) 0∙23 (0∙42, 0∙05) 0∙26 (0∙43, 0∙09) 0∙20 (0∙41, 0∙01) 0∙09 (0∙46, 0∙28) 
 Adjusteda W 0∙30 (0∙50, 0∙10) 0∙30 (0∙50, 0∙11) 0∙23 (0∙46, 0∙02) 0∙12 (0∙37, 0∙13) 0∙24 (0∙60, 0∙12) 
 Adjusteda M 0∙13 (0∙34, 0∙09) 0∙17 (0∙37, 0∙03) 0∙19 (0∙38, 0∙03) 0∙19 (0∙41, 0∙04) 0∙07 (0∙40, 0∙27) 
 
Crude W 1∙75 (2∙39, 5∙89) 1∙49 (4∙99, 2∙00) 3∙28 (5∙91, 0∙65) 5∙58 (9∙55, 1∙61) 3∙85 (8∙95, 1∙24) 
16 : 0 Crude M 0∙37 (2∙75, 3∙49) 2∙11 (5∙09, 0∙86) 0∙95 (3∙88, 1∙97) 3∙93 (7∙36, 0∙51) 1∙89 (5∙93, 2∙16) 
 Adjusteda W 0∙06 (4∙20, 4∙31) 1∙10 (4∙64, 2∙44) 3∙04 (5∙81, 0∙26) 4∙79 (8∙92, 0∙66) 5∙21 (10∙12, 0∙31) 
 Adjusteda M 0∙44 (3∙64, 2∙76) 2∙54 (5∙48, 0∙40) 1∙40 (4∙41, 1∙62) 4∙37 (7∙85, 0∙88) 3∙00 (6∙93, 0∙93) 
 
Crude W 0∙25 (0∙39, 0∙89) 0∙31 (0∙20, 0∙82) 0∙49 (0∙05, 1∙03) 0∙44 (0∙39, 1∙26) 0∙01 (1∙30, 1∙33) 
18 : 0 Crude M 0∙40 (0∙21, 1∙02) 0∙36 (0∙11, 0∙83) 0∙24 (0∙28, 0∙76) 0∙64 (0∙01, 1∙30) 0∙64 (0∙01, 1∙30)  
 Adjusteda W 0∙20 (0∙46, 0∙86) 0∙40 (0∙13,0∙94) 0∙45 (0∙12;1∙02) 0∙47 (0∙34, 1∙29) 0∙13 (1∙38, 1∙12) 
 Adjusteda M 0∙62 (0∙03, 1∙21) 0∙49 (0∙03, 0∙95) 0∙15 (0∙38,0∙70) 0∙71 (0∙06,1∙37) 1∙13 (0∙06, 2∙33) 
 Crude W 1∙66 (5∙55, 2∙22) 7∙18 (11∙87, 2∙48) 11∙10 (16∙71, 5∙48) 8∙69 (16∙90, 0∙48) 15∙91 (28∙00, 3∙82) 
16 : 1n-7 Crude M 2∙99 (0∙17, 6∙14) 2∙08 (1∙48, 5∙66) 2∙99 (1∙54, 7∙52) 6∙04 (1∙61, 13∙70) 6∙15 (8∙51, 20∙80) 
 Adjusteda W 3∙37 (7∙34, 0∙59) 7∙62 (12∙36, 2∙87) 10∙66 (16∙53, 4∙79) 10∙81 (18∙88, 2∙73) 14∙09 (26∙31, 1∙87) 
 Adjusteda M 1∙15 (1∙99, 4∙30) 0∙00 (3∙49, 3∙66) 0∙40 (5∙20, 4∙41) 6∙34 (0∙77, 13∙44) 0∙97 (12∙63, 14∙57) 
 Crude W 0∙00 (10∙53, 10∙52) 6∙37 (14∙62, 1∙87) 4∙82 (13∙10, 3∙47) 2∙37 (11∙84, 7∙09) 7∙77 (21∙75, 6∙21) 
18 : 1n-9 Crude M 9∙30 (2∙56, 2∙17) 7∙91 (1∙31, 14∙52) 9∙48 (2∙22, 16∙74) 15∙48 (6∙95, 24) 9∙27 (5∙49, 2∙03) 
 Adjusteda W 4∙47 (5∙15, 14∙10) 0∙71 (10∙16, 8∙72) 7∙28 (14∙86, 0∙30) 8∙78 (17∙64, 0∙06) 4∙36 (18∙36, 9∙64) 
 Adjusteda M 6∙73 (3∙91, 17∙26) 7∙31 (0∙32, 14∙29) 8∙93 (0∙89, 16∙97) 9∙68 (1∙05, 18∙31) 7∙74 (6∙53, 22) 
 
Crude W 0∙26 (0∙60, 0∙07) 0∙58 (0∙97, 0∙20) 0∙91 (1∙38, 0∙44) 0∙60 (1∙26, 0∙07) 0∙79 (1∙86, 0∙28) 
16 : 1 n-7/16 : 0 Crude M 0∙19 (0∙10, 0∙47) 0∙23 (0∙07, 0∙53) 0∙24 (0∙11, 0∙59) 0∙67 (0∙02, 1∙32) 0∙70 (0∙40, 1∙80) 
 Adjusteda W 0∙25 (0∙63, 0∙13) 0∙69 (1∙10, 0∙27) 1∙13 (1∙63, 0∙63) 0∙97 (1∙59, 0∙34) 1∙09 (2∙18, 0∙01) 
 Adjusteda M 0∙06 (0∙34, 0∙21) 0∙15 (0∙15, 0∙45) 0∙08 (0∙30, 0∙45) 0∙49 (0∙13, 1∙10) 0∙21 (0∙72, 1∙14) 
 
Crude W 0∙74 (4∙32, 5∙80) 1∙53 (5∙63, 2∙56) 4∙84 (8∙31, 1∙36) 7∙50 (12∙46, 2∙54) 9∙95 (16∙67, 3∙23) 
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Tot. SFA Crude M 0∙69 (4∙24, 2∙87) 2∙74 (6∙79, 1∙31) 1∙99 (5∙83, 1∙84) 2∙71 (7∙25, 1∙83) 5-∙55(12∙43, 1∙32) 
 Adjusteda W 0∙07 (5∙22, 5∙09) 2∙24 (6∙11, 1∙63) 3∙93 (7∙58, 0∙27) 6∙44 (11∙46, 1∙43) 8∙24 (15∙21, 1∙27) 
 Adjusteda M 1∙38 (5∙30, 2∙54) 3∙04 (7∙04, 0∙96) 2∙22 (6∙02, 1∙57) 3∙30 (8∙01, 1∙42) 6∙87 (13∙67, 0∙08) 
 
Crude W 9∙14 (21∙63, 3∙34) 10∙32 (22∙14, 1∙50) 14∙12 (26∙01, 2∙22) 22∙07 (36∙09, 8∙05) 15∙87 (42, 10∙27) 
Tot. MUFA Crude M 7∙24 (4∙85, 19∙32) 11∙32 (2∙06, 20∙59) 11∙93 (1∙80, 22∙05) 18∙09 (3∙32, 32∙86) 17∙69 (8∙48, 4386) 
 Adjusteda W 4∙90 (18∙15, 8∙35) 8∙82 (22∙31, 4∙67) 24∙22 (37∙05, 11∙40) 20∙39 (35∙88, 4∙90) 22∙30 (46∙94, 2∙33) 
 Adjusteda M 2∙53 (9∙91, 14∙98) 7∙07 (2∙27, 16∙41) 3∙68 (6∙27, 13∙64) 13∙71 (0∙46, 27∙88) 17∙33 (5∙46, 40∙13) 
To improve readability, percentile difference values were multiplied by 100.  aModel adjusted for sex, physical activity, and smoking. 
 
 
 
Table 8a: Percentile differences (PD) with 95% confidence intervals (CI) at the 10th, 25th, 50th, 75th and 90th percentile of serum fatty acids across levels of Sandwiches. Results represent 
quantile change in fatty acids for each points increase of Sandwiches in crude and adjusted model in 4,030 participants of a Swedish cohort of 60-year-olds. 
Sandwiches 
Percentiles differences of fatty acids 
FA  10 th 25 th 50 th 75 th 90 th 
20:4 n-6 
Crude 30∙96 (50∙34;11∙59) 26∙98 (42∙70, 11∙25) 29∙27 (45∙29, 13∙24) 35 (54∙79, 15∙20) 41∙47 (72∙94, 10∙01) 
Adjusted1 25∙52 (46∙97, 4∙06) 26∙34 (42∙37, 10∙31) 30∙23 (46∙83, 13∙63) 33∙78 (54∙35, 13∙21) 44∙34 (74∙45, ∙14∙22) 
18:3 n-3 
Crude 6∙67 (2∙95, 10∙38) 5∙74 (3∙00, 8∙48) 6∙78 (4∙059∙51) 8∙62 (5∙08, 12∙16) 9∙60 (4∙56, 14∙64) 
Adjusted1 5∙71 (2∙10, 9∙32) 5∙23 (2∙35, 8∙12) 6∙48 (3∙59, 9∙37) 9∙93 (6∙61, 13∙25) 10∙26 (5∙43, 15∙08) 
1 Model adjusted for sex, physical activity and smoking. To show the exact changes in percentiles of fatty acids the beta coefficient values have been multiplied by 100. 
 
Table 8b: Percentile differences (PD) with 95% confidence intervals (CI) at the 10th, 25th, 50th, 75th and 90th percentile of serum fatty acids across levels of Fruits. Results represent 
quantile change in fatty acids for each points increase of Fruits in crude and adjusted model in 4,030 participants of a Swedish cohort of 60-year-olds. 
 
 
Fruits 
Percentiles differences of fatty acids 
FA  10 th 25 th 50 th 75 th 90 th 
EPA 
Crude 8∙01 (5∙12, 10∙91) 8∙17 (4∙74, 11∙60) 7∙32 (3∙14, 11∙50) 8∙43 (2∙64, 14∙23) 12∙10 (0∙25, 23∙96) 
Adjusted1 4∙73 (1∙38, 8∙07) 6∙77 (3∙14, 10∙39) 5∙78 (1∙28, 10∙28) 9∙02 (2∙23, 15∙80) 10∙87 (0∙66, 22∙40) 
DHA 
Crude 3∙18(1∙99, 4∙37) 4∙43 (3∙22, 5∙63) 4∙58 (3∙37, 5∙79) 4∙63 (3∙18, 6∙08) 5∙82 (3∙34, 8∙29) 
Adjusted1 1∙88 (0∙61, 3∙16) 3∙43 (2∙04, 4∙82) 3∙96 (2∙71, 5∙21) 4∙42 (2∙87, 5∙98) 5∙40 (2∙86, 7∙93) 
 
1 Model adjusted for sex, physical activity and smoking. To show the exact changes in percentiles of fatty acids the beta coefficient values have been multiplied by 100. 
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Table 8c: Percentile differences (PD) with 95% confidence intervals (CI) at the 10th, 25th, 50th, 75th and 90th percentile of serum fatty acids across levels of Vegetables. Results represent 
quantile change in fatty acids for each points increase of  Vegetables in crude and adjusted model in 4,030 participants of a Swedish cohort of 60-year-olds. 
Vegetables 
Percentiles differences of fatty acids 
FA  10 th 25 th 50 th 75 th 90 th 
18:1 n-9 
Crude 25∙51 (39∙26, 11∙77) 21∙14 (31∙13, 11∙15) 23∙85 (34∙31, 13∙40) 33∙19 (44∙31, 22∙08) 46∙32 (64∙17, 28∙46) 
Adjusted1 16∙14 (30∙63, 1∙64) 22∙56 (32∙59, 12∙52) 24∙71 (35∙04, 14∙37) 22∙66 (34∙96, 10∙36) 40∙27 (57∙51, 23∙02) 
EPA 
Crude 6∙51 (2∙86;10∙16) 10∙48 (6∙74;14∙23) 15∙68 (11∙43;19∙93) 17∙32 (10∙03;24∙60) 32∙20 (19∙69;44∙70) 
Adjusted1 4∙57 (1∙01;8∙12) 9∙38 (5∙48;13∙27) 15∙30 (10∙88;19∙73) 15∙71 (8∙56;22∙86) 28∙13 (15∙57;40∙69) 
DHA 
Crude 4∙00 (2∙71;5∙29) 4∙82 (3∙39;6∙25) 5∙26 (3∙97;6∙56) 5∙25 (3∙58;6∙92) 7∙43 (4∙70;10∙17) 
Adjusted1 2∙95 (1∙76;4∙14) 3∙77 (2∙40;5∙15) 4∙41 (3∙00;5∙83) 5∙06 (3∙27;6∙87) 5∙25 (2∙40;8∙09) 
 Crude 85∙07 (46∙92;123∙23) 56∙29 (35∙52, 80∙06) 24∙48 (8∙75, 40∙21) 34∙67 (17∙78, 51∙55) 26∙26 (4∙72, 4∙78) 
PUFA Adjusted1 64∙34 (29∙14, 99∙53) 32∙64 (10∙17, 55∙10) 21∙26 (2∙56, 39∙97) 21∙31(4∙14, 38∙50) 23∙59 (0∙75, 44∙44) 
1 Model adjusted for sex, physical activity and smoking. To show the exact changes in percentiles of fatty acids the beta coefficient values have been multiplied by 100. 
 
 
 
 
 
Table 8d: Percentile differences (PD) with 95% confidence intervals (CI) at the 10th, 25th, 50th, 75th and 90th percentile of serum fatty acids across levels of Potato dishes. Results 
represent quantile change in fatty acids for each points increase of Potato dishes in crude and adjusted model in 4,030 participants of a Swedish cohort of 60-year-olds. 
Potato dishes 
Percentiles differences of FA 
FA  10 th 25 th 50 th 75 th 90 th 
EPA 
Crude 8∙91 (12∙76, 5∙06) 8∙83 (12∙60, 5∙06) 8∙46 (13∙03, 3∙90) 11∙65 (18∙08, 5∙21) 16∙20 (29∙61, 2∙80) 
Adjusted1 6∙16 (9∙94, 2∙38) 8∙56 (12∙76, 4∙37) 8∙63 (13∙43, 3∙82) 13∙43 (20∙84, 6∙02) 17∙12 (30∙35, 3∙88) 
DHA 
Crude 3∙30 (4∙70, 1∙90) 3∙49 (4∙80, 2∙20) 3∙44 (4∙75, 2∙14) 4∙02 (5∙62, 2∙41) 6∙49 (9∙05, 3∙93) 
Adjusted1 2∙27 (3∙81, 0∙74) 3∙11(4∙55, 1∙67) 3∙17 (4∙58, 1∙76) 4∙31 (6∙10, 2∙51) 6∙81 (9∙42, 4∙20) 
 
1 Model adjusted for sex, physical activity and smoking. To show the exact changes in percentiles of fatty acids the beta coefficient values have been multiplied by 100. 
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Table 8e: Percentile differences (PD) with 95% confidence intervals (CI) at the 10th, 25th, 50th, 75th and 90th percentile of serum fatty acids across levels of Dessert and Snack. Results 
represent quantile change in fatty acids for each points increase of Dessert and Snack in crude and adjusted model in 4,030 participants of a Swedish cohort of 60-year-olds. 
Dessert and Snack 
Percentiles differences of fatty acids 
FA  10 th 25 th 50 th 75 th 90 th 
16:0 
Crude 9∙75 (13∙77, 5∙74) 11∙89(15∙96, 8∙42) 12∙78 (16∙40, 9∙17) 14∙23 (18∙19, 10∙28) 11∙38 (17∙48, 5∙29) 
Adjusted1 10∙11 (14∙55, 5∙66) 12∙65(16∙44, 8∙87) 12∙85 (16∙27, 9∙43) 14∙29 (18∙70, 9∙88) 9∙63 (15∙01, 4∙25) 
16:1 n-7 
Crude 9∙13 (13∙67, 4∙59) 12∙42 (17∙96, 6∙87) 21∙77 (27∙76, 15∙77) 31∙04 (40∙43, 21∙65) 60∙38 (75∙55, 45∙22) 
Adjusted1 6∙79 (11∙58, 2∙00) 12∙70 (17∙61,7∙80) 21∙12 (26∙87, 15∙36) 29∙17 (37∙71, 20∙62) 47∙36 (63∙20, 31∙53) 
18:2 n-6 
Crude 118∙51 (84∙51, 152∙52) 87∙91 (63∙07, 112∙74) 76∙27 (55∙85, 96∙68) 51∙34 (29∙78, 72∙91) 31∙52 (5∙59, 57∙45) 
Adjusted1 89∙92 (53∙83,  126∙03) 83∙10 (59∙10, 107∙10) 71∙35 (51∙17, 91∙54) 61∙97 (40∙71, 82∙24) 25∙51 (2∙84, 48∙18) 
Tot n-6 
Crude 78∙53 (46∙33, 110∙73) 68∙52 (48∙12, 88∙92) 44∙62 (30∙13, 59∙10) 36∙97 (19∙72, 54∙22) 26∙79 (4∙68, 48∙89) 
Adjusted1 80∙96 (45∙11, 116∙80) 61∙59 (41∙09, 82∙10) 56∙03 (39∙19, 73∙88) 33∙07 (15∙47, 50∙66) 33∙60 (11∙70, 55∙50) 
 Crude 78∙53 (43∙33, 110∙73) 68∙52 (48∙12, 88∙92) 44∙62 (30∙13, 59∙10) 36∙21 (20∙88, 51∙53) 29∙57 (11∙34, 47∙79) 
Tot PUFA Adjusted1 76∙59 (41∙69, 11∙50) 58∙48 (38∙44, 78∙53) 44∙84 (29∙40, 60∙28) 25∙42 (20∙41, 50∙44) 32∙12 (12∙89, 51∙35) 
 
1 Model adjusted for sex, physical activity and smoking. To show the exact changes in percentiles of fatty acids the beta coefficient values have been multiplied by 100. 
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Table 9a:  Risk of Incident Cardio Vascular Disease (CVD) and Total Mortality According to Sex-specific Quartiles of Serum Cholesteryl Ester Eicosapentaenoic acid (EPA) and 
Docosahexaenoic Acid (DHA). Sex specific results based on the participants of the cohort of 60-year-old men and women. 
 
  Quartiles of EPA  
  1 2 3 4 Ptrend 
Female Median EPA, % of TFA  1.24 1.66 2.13 3.05  
  CVD incidence Events (person-years) 60 (6371) 42 (6653) 42 (6648) 39 (6797)  
 Crude HR (95% CI) 1.00 (reference) 0.67(0.45-0.99) 0.62(0.41-0.93) 0.60(0.40-0.90) 0.032 
 Adjusted HR (95% CI) 1.00 (reference) 0.65(0.44-0.98) 0.64(0.43-0.97) 0.59(0.39-0.91) 0.043 
  All-cause mortality Deaths (person-years) 61 (6708) 43 (6893) 54 (6841) 33 (6976)  
 Crude HR (95% CI) 1.00 (reference) 0.68 (0.46-1.01) 0.86 (0.60-1.25) 0.52 (0.34-0.79) 0.007 
 Adjusted HR (95% CI) 1.00 (reference) 0.68 (0.46-1.01) 0.90 (0.62-1.31) 0.53 (0.34-0.82) 0.015 
       
Male Median EPA, % of TFA  1.16 1.66 2.14 3.08  
  CVD incidence Events (person-years) 77 (5,466) 81 (5,548) 74 (5,599) 72 (5,661)  
 Crude HR (95% CI) 1.00 (reference) 1.04(0.76-1.42) 0.94(0.68-1.29) 0.90(0.65-1.24) 0.41 
 Adjusted HR (95% CI) 1.00 (reference) 1.09(0.79-1.49) 0.99(0.71-1.38) 0.99(0.70-1.40) 0.80 
  All-cause mortality Deaths (person-years) 81 (5,879) 70 (5,971) 65 (5,990) 49 (6,077)  
 Crude HR (95% CI) 1.00 (reference) 0.85 (0.62-1.17) 0.78 (0.56-1.08) 0.59 (0.41-0.83) 0.002 
 Adjusted HR (95% CI) 1.00 (reference) 0.85 (0.61-1.18) 0.82 (0.58-1.14) 0.62 (0.43-0.91) 0.014 
 
  Quartiles of DHA  
  1 2 3 4 Ptrend 
       
Female Median DHA, % of TFA 1.24 1.66 2.13 3.05  
  CVD incidence Events (person-years) 60 (6371) 42 (6653) 42 (6648) 39 (6797)  
 Crude HR (95% CI) 1.00 (reference) 0.67(0.45-0.99) 0.62(0.41-0.93) 0.60(0.40-0.90) 0.032 
 Adjusted HR (95% CI) 1.00 (reference) 0.65(0.44-0.98) 0.64(0.43-0.97) 0.59(0.39-0.91) 0.043 
  All-cause mortality Deaths (person-years) 61 (6708) 43 (6893) 54 (6841) 33 (6976)  
 Crude HR (95% CI) 1.00 (reference) 0.68 (0.46-1.01) 0.86 (0.60-1.25) 0.52 (0.34-0.79) 0.007 
 Adjusted HR (95% CI) 1.00 (reference) 0.68 (0.46-1.01) 0.90 (0.62-1.31) 0.53 (0.34-0.82) 0.015 
       
Male Median DHA, % of TFA 1.16 1.66 2.14 3.08  
  CVD incidence Events (person-years) 77 (5,466) 81 (5,548) 74 (5,599) 72 (5,661)  
 Crude HR (95% CI) 1.00 (reference) 1.04(0.76-1.42) 0.94(0.68-1.29) 0.90(0.65-1.24) 0.41 
 Adjusted HR (95% CI) 1.00 (reference) 1.09(0.79-1.49) 0.99(0.71-1.38) 0.99(0.70-1.40) 0.80 
  All-cause mortality Deaths (person-years) 81 (5,879) 70 (5,971) 65 (5,990) 49 (6,077)  
 Crude HR (95% CI) 1.00 (reference) 0.85 (0.62-1.17) 0.78 (0.56-1.08) 0.59 (0.41-0.83) 0.002 
 Adjusted HR (95% CI) 1.00 (reference) 0.85 (0.61-1.18) 0.82 (0.58-1.14) 0.62 (0.43-0.91) 0.014 
CVD, cardiovascular disease; HR, hazard ratio; DHA, docosahexaenoic acid; TFA, total fatty acids 
1Adjusted for smoking, physical activity, education, BMI, alcohol intake, diabetes, hypertension, hypercholesterolemia. 
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Table 9b: Risk of Incident Cardio Vascular Disease (CVD) and Total Mortality According to Sex-specific Quartiles of Serum Cholesteryl Ester linoleic acid (LA) and 
linolenic Acid (ALA). Sex specific results based on the participants of the cohort of 60-year-old men and women. 
 
  Quartiles of LA  
  1 2 3 4 Ptrend 
Female Median LA, % TFA  43.8 47.4 49.9 53.0  
  CVD incidence Events (person-years) 52 (6,583) 41 (6,661) 42 (6,694) 45 (6,531)  
 Crude HR (95% CI) 1.00 (reference) 0.78 (0.52-1.17) 0.79 (0.53-1.19) 0.87 (0.59-1.30) 0.50 
 Adjusted HR (95% CI) 1.00 (reference) 0.86 (0.57-1.32) 0.94 (0.61-1.44) 1.08 (0.70-1.66) 0.74 
  All-cause mortality Deaths (person-years) 55 (6,828) 39 (6,910) 50 (6,872) 47 (6,807)  
 Crude HR (95% CI) 1.00 (reference) 0.70 (0.46-1.05) 0.90 (0.62-1.32) 0.86 (0.58-1.27) 0.63 
 Adjusted HR (95% CI) 1.00 (reference) 0.75 (0.49-1.15) 1.00 (0.67-1.50) 0.96 (0.63-1.47) 0.92 
       
Male Median LA, % TFA  43.8 47.6 50.1 53.0  
  CVD incidence Events (person-years) 79 (5,401) 84 (5,517) 64 (5,708) 77 (5,649)  
 Crude HR (95% CI) 1.00 (reference) 1.04 (0.76-1.41) 0.76 (0.55-1.06) 0.93 (0.68-1.27) 0.32 
 Adjusted HR (95% CI) 1.00 (reference) 1.11 (0.81-1.51) 0.83 (0.59-1.17) 1.03 (0.73-1.44) 0.77 
  All-cause mortality Deaths (person-years) 84 (5,851) 74 (5,946) 56 (6,065) 51 (6,056)  
 Crude HR (95% CI) 1.00 (reference) 0.86 (0.63-1.18) 0.63 (0.45-0.89) 0.58 (0.41-0.82) <0.001 
 Adjusted HR (95% CI) 1.00 (reference) 0.90 (0.65-1.23) 0.64 (0.45-0.90) 0.59 (0.41-0.85) 0.001 
 
 
  Quartiles of ALA  
  1 2 3 4 Ptrend 
       
Female Median ALA, % of TFA  0.69 0.82 0.94 1.11  
  CVD incidence Events (person-years) 33 (6637) 45 (6606) 46 (6626) 56 (6601)  
 Crude HR (95% CI) 1.00 (reference) 1.38 (0.88-2.16) 1.40 (0.90-2.20) 1.72 (1.12-2.64) 0.015 
 Adjusted HR (95% CI) 1.00 (reference) 1.43 (0.91-2.24) 1.47 (0.93-2.31) 1.72 (1.12-2.66) 0.016 
  All-cause mortality Deaths (person-years) 45 (6840) 46 (6824) 52 (6878) 48 (6876)  
 Crude HR (95% CI) 1.00 (reference) 1.03 (0.68-1.55) 1.16 (0.78-1.72) 1.07 (0.71-1.60) 0.67 
 Adjusted HR (95% CI) 1.00 (reference) 1.02 (0.67-1.55) 1.15 (0.79-1.72) 1.02 (0.68-1.55) 0.82 
       
Male Median ALA, % of TFA 0.66 0.88 0.92 1.09  
  CVD incidence Events (person-years) 77 (5,569) 83 (5,558) 72 (5,586) 72 (5,561)  
 Crude HR (95% CI) 1.00 (reference) 1.08 (0.79-1.47) 0.93 (0.68-1.29) 0.94 (0.68-1.29) 0.52 
 Adjusted HR (95% CI) 1.00 (reference) 1.16 (0.85-1.58) 0.97 (0.70-1.34) 1.02 (0.74-1.42) 0.86 
  All-cause mortality Deaths (person-years) 62 (5,967) 58 (6,034) 70 (5,976) 75 (5,940)  
 Crude HR (95% CI) 1.00 (reference) 0.92 (0.64-1.31) 1.13 (0.80-1.59) 1.22 (0.87-1.71) 0.15 
 Adjusted HR (95% CI) 1.00 (reference) 0.97 (0.67-1.39) 1.12 (0.79-1.58) 1.23 (0.88-1.73) 0.16 
CVD, cardiovascular disease; HR, hazard ratio; ALA, α-linolenic acid, TFA, total fatty acids 
1Adjusted for smoking, physical activity, education, BMI, alcohol intake, diabetes, hypertension, and hypercholesterolemia. 
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